Emmanouil S. Brilakis, MD, PhD - UT Southwestern Medical ...€¦ · office: 214-857-1547 fax: 214-302-1341 [email protected] [email protected] [email protected]

1

Emmanouil S. Brilakis, MD, PhD DATE PREPARED: October 10, 2013

CONTACT INFORMATION

WORK Dallas VA Medical Center (111A) 4500 South Lancaster Road, Dallas, TX 75216 office: 214-857-1547 fax: 214-302-1341 [email protected] [email protected] [email protected]

WORK EXPERIENCE 2004 - Director, Cardiac Catheterization Laboratories, Dallas VA Medical Center,

Dallas, TX

PRESENT ACADEMIC RANK AND POSITION 9/2010 - Associate Professor in Medicine, University of Texas Southwestern, Dallas, Texas 2004 - 2010 Assistant Professor in Medicine, University of Texas Southwestern, Dallas, Texas 2004 Assistant Professor in Medicine, Mayo Medical School, Rochester, Minnesota 2001-2004 Instructor in Medicine, Mayo Medical School, Rochester, Minnesota

EDUCATION AND TRAINING

2007 Training in Cardiac Computed Tomography, Lenox Hill Heart and Vascular Institute, New York, New York

2005 PhD in Clinical Research, School of Medicine, National University of Athens,

Greece 2003-2004 Fellow in Interventional Cardiology, Mayo Clinic, Rochester, Minnesota 2/2004 Masters in Clinical Research, Mayo Graduate School, Rochester, Minnesota 2000-2003 Fellow in Cardiology, Mayo Clinic, Rochester, Minnesota 1997-2000 Resident in Internal Medicine, Mayo Clinic, Rochester, Minnesota 1995-7 Resident in Internal Medicine, General Military Hospital, Athens and Xanthi,

Greece 1989-95 Doctor of Medicine, High Honors, School of Medicine, National University of

Athens, Greece

mailto:[email protected]



2

RESEARCH FUNDING

ONGOING STUDIES

4/2012-3/2016

Department of Veterans Affairs - Prasugrel for prevention of early saphenous vein graft thrombosis – I01-CX000787-01 - $650,000 – NCT01121224 - PI This is a randomized, controlled pilot trial of prasugrel vs. placebo in patients undergoing clinically-indicated coronary artery bypass graft surgery. The primary endpoint is the prevalence of saphenous vein graft thrombus, as assessed by optical coherence tomography at 12 month follow-up angiography.

2009-2013 Department of Veterans Affairs - VA Cooperative Study No. 571. Drug-eluting stents vs. Bare Metal Stents In saphenous Vein graft Angioplasty (DIVA) -

$10,755,297 – NCT01121224 - PI and Study Chair Multicenter, randomized, controlled, double-blinded trial of drug-eluting vs. bare metal stents in de novo saphenous vein graft lesions.

8/2010-4/2014

National Institutes of Health – Extended-Release Niacin for Saphenous Vein

Graft Atherosclerosis - 1R01HL102442-01A1 - $1,068,400 - NCT01221402 - PI This is a randomized-controlled trial of extended-release niacin vs. placebo in patients with intermediate saphenous vein graft lesions. The primary endpoint of the study is change in saphenous vein graft percent atheroma volume.

2010-2013 Department of Veterans Affairs – CCTA 002 - Plaque Regression and Progenitor Cell Mobilization with Intensive Lipid Elimination Regimen (PREMIER)-– Site PI This is a multicenter, randomized, controlled, trial of LD-apheresis vs. standard medical therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention.

2009-2012 Department of Veterans Affairs –AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusions - the ACE-CTO Study – NCT01012869 - PI This is prospective single-arm study examining the angiographic and intravascular imaging findings after implantation of the everolimus-eluting stent in chronic total coronary occlusions

2010-2013 Department of Veterans Affairs – Cardiac CAtheterization for Bypass Graft Patency Rate Optimization: the CABG-PRO Randomized-controlled Pilot Study– NCT01063491 - PI This is randomized-controlled clinical trial examining the effect of pre-discharge coronary angiography after coronary artery bypass graft surgery on bypass graft patency at 12 months follow-up angiography

2010-2013 Department of Veterans Affairs –RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial – NCT01446263 - PI This is single-center randomized-controlled clinical trial comparing radial vs. femoral access in patients with prior coronary artery bypass graft surgery undergoing coronary angiography and intervention

3

COMPLETED STUDIES

2009-2011 Abbott Vascular - Prospective Evaluation of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis - $141,000 - PI This study will examine the clinical and angiographic outcomes after implantation of the Xience V everolimus-eluting stent in saphenous vein graft lesions.

2007-2008 UT Arlington – UT Southwestern Joint Venture Grant for Collaborative Research Co-PI $100,000 Development of a novel biodegradable stent in collaboration with Drs Jian Yang and Panos Shiakolas (Department of Bioengineering and Mechanical Engineering, University of Texas Arlington)

2006 Clark R. Gregg fund, Harris Methodist Foundation Grant. PI $80,000 Multicenter enrollment support for the SOS (Stenting Of Saphenous vein grafts) randomized-controlled trial of a paclitaxel-eluting stent vs. a bare metal stent in saphenous vein graft lesions

6/2005-6/2007

Veterans Affairs VISN-17 Startup Award. PI $100,000 Research Coordinator support for the SOS (Stenting Of Saphenous vein grafts) randomized-controlled trial of a paclitaxel-eluting stent vs. a bare metal stent in saphenous vein graft lesions

2004 Dallas VA Research Corporation Startup Grant. PI $20,000 The SOS (Stenting Of Saphenous vein grafts) randomized-controlled trial of a paclitaxel-eluting stent vs. a bare metal stent in saphenous vein graft lesions

LICENSURE 2011- Georgia 2004- Texas 2000-2005 Arizona 1999-2004 Minnesota

PUBLICATIONS Original manuscripts: 194 Editorials: 28 Letters to the editor: 13 Book chapters: 13 Total: 247 h-index: 23

Most Important

1. Brilakis ES, Patel VG, Banerjee S. Medical management after coronary stent implantation: a review. JAMA 2013; 310:189-98

4

2. Brilakis ES, Grantham JA, Rinfret S, Wyman RM, Burke MN, Karmpaliotis D, Lembo N, Pershad A, Kandzari DE, Buller CEH and others. A Percutaneous Treatment Algorithm for Crossing Coronary Chronic Total Occlusions. JACC Cardiovasc Interv 2012:5:367-379. PMID: 22516392

3. Brilakis ES, Rao SV, Banerjee S, Goldman S, Shunk K, Holmes DR, Honeycutt E, Roe MT. Percutaneous Coronary Intervention in Native Arteries vs. Bypass Grafts in Prior Coronary Bypass Grafting Patients: A Report from NCDR. JACC Cardiovasc Interv 2011; 4: 844-850, PMID: 21851896

4. Brilakis ES, Lichtenwalter, C, Abdel-karim AR, de Lemos JA, Roesle M, Obel OO, Addo TA, Haagen D,

Rangan BV, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger, PB, Banerjee S. Continued Benefit from Paclitaxel-Eluting Compared to Bare Metal Stent Implantation in Saphenous Vein Graft Lesions During Long-Term Follow-Up of the SOS (Stenting Of Saphenous vein grafts) Trial. JACC Cardiovasc Interv 2011;4:176-182, PMID: 21349456

5. Brilakis ES, Wang TY, Rao SV, Banerjee S, Goldman S, Shunk K, Kar B, Holmes DR, Dai D, Chin CT,

Harding TM, Roe MT. Frequency and Predictors of Drug-Eluting Stent Use in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions: A Report from the American College of Cardiology National Cardiovascular Data CathPCI Registry®. JACC Cardiovasc Interv 2010; 3:1068-1073, PMID: 20965466

6. Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, Saeed B, Gadiparthi C, Bissett

JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S. A Randomized-Controlled Trial Of A Paclitaxel-Eluting Stent vs. A Similar Bare Metal Stent In Saphenous Vein Graft Lesions. The SOS (Stenting Of Saphenous Vein Grafts) Trial. J Am Coll Cardiol 2009:53:919–28, PMID: 19281920

7. Brilakis ES, Hernandez, AF, Dai D, Peterson ED, Banerjee S, Fonarow GC, Cannon, CP, Bhatt DL.

Quality of Care for Acute Coronary Syndrome Patients With Known Atherosclerotic Disease: Results from the Get With the Guidelines Program. Circulation 2009;120:560-567, PMID: 19652090

8. Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, Saeed B, Gadiparthi C, Bissett JK, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger PB, Banerjee S, Brilakis ES. Clinical Presentation and Angiographic Characteristics of Saphenous Vein Graft Failure after Stenting: Insights from the Stenting Of Saphenous Vein Grafts Trial. JACC Cardiovasc Interv 2009;2:855-860. PMID: 19778774

9. Brilakis ES, McConnell JP, Lennon RJ, Elesber AA, Meyer JG, Berger PB. Association of Lipoprotein-

Associated Phospholipase A2 Levels With Coronary Artery Disease Risk Factors, Angiographic Coronary Artery Disease, and Cardiovascular Events at Follow-Up. Eur Heart J 2005;26:137-44, PMID: 15618069

10. Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger

PB.Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 2005;353(1):46-57, PMID: 16000355

In press

1. Michael TT,Alomar M, Papayannis A, Mogabgab O, Patel VG, Rangan BV, Luna M, Hastings JL, Grodin J, Abdullah S, Banerjee S, Brilakis ES. A Randomized Comparison of Transradial versus Transfemoral Approach for Coronary Artery Bypass Graft Angiography and Intervention (the RADIAL CABG trial). JACC Cardiovasc Interv 2013; in press.

5

2. Lo N, Michael TT, Moin D, Patel VG, Banerjee A, Cipher D, Brilakis ES. Periprocedural Myocardial Injury in Chronic Total Occlusion Percutaneous Interventions: a Systematic Cardiac Biomarker Evaluation Study. JACC Cardiovasc Interv 2013; in press.

3. Patel VG, Brayton KM, Mintz GS, Maehara A, Banerjee S, Brilakis ES. Intracoronary and Non-Invasive

Imaging for Prediction of Distal Embolization and Periprocedural Myocardial Infarction During Native Coronary Artery Percutaneous Intervention. Circ Cardiovasc Imaging 2013;in press

4. Patel VG, Michael TT, Mogabgab O, Fuh E, Alomar M, Rangan BV, Abdullah S, Banerjee S, Brilakis ES.

Complications During Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2013;in press

5. Mogabgab O, Patel VG, Michael TT, Fuh E, Alomar M, Rangan BV, Abdullah S, Banerjee S, Brilakis ES.

Long-Term Outcomes with use of the BridgePoint Medical System for the Recanalization of Coronary Chronic Total Occlusions. J Invasive Cardiol. 2013;in press

6. Fuh E, Brilakis ES. Comparative Intravascular Imaging For Lipid Core Plaque: VH-IVUS vs. OCT vs.

NIRS. J Invasive Cardiol. 2013;in press

7. Sherbet DP, Garg P, Brilakis ES, Banerjee S. Low-Density Lipoprotein Cholesterol: How Low Can We Go? Am J Cardiovasc Drugs. 2013 Apr 23. [Epub ahead of print]

8. Patel V, Zankar A, Brilakis ES. Use of the Retrograde Approach for Primary Percutaneous Coronary

Intervention of an Inferior ST-Segment Elevation Myocardial Infarction. J Invasive Cardiol 2013; in press

9. Brilakis ES, Kotsia A, Luna M, Garcia S, Abdullah SM, Banerjee S. The role of drug-eluting stents for the treatment of coronary chronic total occlusions. Expert Review of Cardiovascular Therapy 2013; in press

10. Alomar ME, Michael TT, Patel VG, Altomare CG, Rangan BV, Cipher D, Banerjee S, Brilakis ES. Stent loss and retrieval during percutaneous coronary interventions: a systematic review and meta-analysis. J Invasive Cardiol. 2013;in press

11. Michael TT, Mogabgab O, Fuh E, Patel VG, El Sabbagh M, Alomar M, Rangan BV, Abdullah SM, Banerjee S, Brilakis ES. Application of the “Hybrid Approach” To Chronic Total Occlusion Interventions: a Detailed Procedural Analysis. J Interv Cardiol. 2013;in press

12.

2013

1. Patel VG, Brayton K, Tamayo A, Mogabgab O, Michael TT, Lo N, Alomar M, Shorrock D, Abdullah A, Banerjee S, Brilakis ES. Incidence of Angiographic Success and Procedural Complications in Patients Undergoing Percutaneous Coronary Chronic Total Occlusion Interventions: A Weighted Meta-Analysis of 18,061 Patients from 65 Studies JACC Cardiovasc Interv 2013;6:128-136

2. Brilakis ES, Held C, Meier B, Cools F, Claeys M, Cornel J, Aylward P, Lewis B, Weaver D, Wognsen GB, Stevens S, Wallentin L, James S. Effect of ticagrelor on the outcomes of patients with prior coronary artery

http://www.ncbi.nlm.nih.gov/pubmed/23609530

6

bypass graft surgery: Insights from the platelet inhibition and patient outcomes (PLATO) trial. Am Heart J 2013;166:474-80

3. Marmagkiolis K, Brilakis ES, Hakeem A, Cilingiroglu M, Bilodeau L. Saphenous vein graft perforation during percutaneous coronary intervention: a case series. J Invasive Cardiol. 2013;25:157-61

4. Alshawabkeh L, Prasad A, Lenkovsky F, Makary LF, Kandil E, Weideman R, Kelly K, Rangan BV, Banerjee S, Brilakis ES. Outcomes of a preoperative “bridging” strategy with glycoprotein IIb/IIIa inhibitors for preventing perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration. Eurointervention 2013; 9:204-11

5. Garcia S, Abdullah S, Banerjee S, Brilakis ES. Chronic total occlusions: patient selection and overview of advanced techniques. Curr Cardiol Rep. 2013;15:334

6. Papayannis AC, Cipher D, Banerjee S, Brilakis ES. Optical Coherence Tomography Evaluation of Drug-Eluting Stents: a Systematic Review. Catheter Cardiovasc Interv 2013; 81:481-7

7. Papayannis AC, Abdel-karim AR, Mahmood A, Rangan BV, Makke LB, Banerjee S, Brilakis ES. Association of Coronary Lipid Core Plaque with Intra-stent Thrombus Formation: A Near-Infrared Spectroscopy and Optical Coherence Tomography Study. Catheter Cardiovasc Interv 2013; 81:488-93

8. Frick K, Michael TT, Alomar M, Mohammed A, Rangan BV, Abdullah S, Banerjee S, Brilakis ES. Low Molecular Weight Dextran Provides Similar Optical Coherence Tomography Coronary Imaging Compared to Radiographic Contrast Media. Catheter Cardiovasc Interv 2013; published online before print

9. Moussa ID, Klein LW, Shah B, Mehran R, Mack MJ, Brilakis ES, Reilly JP, Zoghbi G, Holper E, Stone

GW. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization an expert consensus document from the society for cardiovascular angiography and interventions (SCAI). Catheter Cardiovasc Interv 2013; published online before print

10. Madder RD, Goldstein JA, Madden SP, Puri R, Wolski K, Hendricks M, Sum ST, Kini A, Sharma S, Rizik D, Brilakis ES, Shunk KA, Petersen J, Weisz G, Virmani R, Nicholls SJ, Maehara A, Mintz GS, Stone GW, Muller JE. Detection by Near-Infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites in Patients With Acute ST-Segment Elevation Myocardial Infarction. JACC Cardiovasc Interv 2013; 6:838-46

11. Garcia S, Sandoval Y, Roukoz H, Adabag S, Canoniero M, Yannopoulos D, Brilakis ES. Outcomes after Complete versus Incomplete Revascularization of Patients with Multivessel Coronary Artery Disease. A Meta-Analysis of 92,569 Patients Enrolled in Randomized Clinical Trials and Observational Studies. J Am Coll Cardiol 2013;published online before print

12. Michael TT, Karmpaliotis D, Brilakis ES, Abdullah SA, Kirkland BL, Mishoe KL, Lembo N, Kalynych A, Carlson H, Banerjee S, Lombardi WL, Kandzari DE. Impact of Prior Coronary Artery Bypass Graft Surgery on Chronic Total Occlusion Revascularization: Insights from a Multicenter US Registry. Heart 2013;99:1515-8

13. Michael TT, Karmpaliotis D, Brilakis ES, Fuh E, Patel V, Mogabgab O, Kirkland BL, Lembo N, Kalynych A, Carlson H, Banerjee S, Lombardi WL, Kandzari DE. Procedural Outcomes of Revascularization of Chronic Total Occlusion of Native Coronary Arteries (from a Multicenter United States Registry). Am J Cardiol 2013; 112:488-92

7

14. Townsend JC, Steinberg DH, Nielsen CD, Todoran TM, Patel CP, Leonardi RA, Wolf BJ, Brilakis ES, Shunk KA, Goldstein JA, Kern MJ, Powers ER. Comparison of Lipid Deposition at Coronary Bifurcations Versus at Non-bifurcation Portions of Coronary Arteries as Determined by Near-infrared Spectroscopy. Am J Cardiol 2013;112:369-72

15. Xu H, Kona S, Su LC, Tsai YT, Dong JF, Brilakis ES, Tang L, Banerjee S, Nguyen KT. Multi-Ligand Poly(L-Lactic-co-Glycolic Acid) Nanoparticles Inhibit Activation of Endothelial Cells. J Cardiovasc Transl Res. 2013;6:570-8

16. Abdel-karim AR, da Silva M, Lichtenwalter C, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan

BV, Makke L, Jeroud OM, Raghunathan D, Saeed B, Bissett JK, Saschdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger PB, Banerjee S, Brilakis ES. Prevalence and Outcomes of Intermediate Saphenous Vein Graft Lesions: Findings from the Stenting Of Saphenous Vein Grafts Randomized-Controlled Trial. Int J Cardiol 2013; published online before print

17. Patel VG, Banerjee S, Brilakis ES. Treatment of inadvertent subintimal stenting during percutaneous intervention of a coronary chronic total occlusion. Interventional Cardiology 2013; 5:165-169

18. Bagai J, Banerjee S, Brilakis ES. Combination antithrombotic management of non-ST segment elevation acute coronary syndromes. Interventional Cardiology Clinics 2013; published online before print

19. Michael TT, Banerjee S, Brilakis ES. Subintimal distal anchor technique for “balloon uncrossable” chronic total occlusions. J Invasive Cardiol. 2013; 25:552-554

2012

1. Michael TT, Papayannis AC, Banerjee S, Brilakis ES. Subintimal Dissection/Re-entry Strategies in Coronary Chronic Total Occlusion Interventions. Circ Cardiovasc Interv 2012:5:729-738 PMID: 23074346

2. Brilakis ES, Grantham JA, Thompson CA, DeMartini TJ, Prasad A, Sandhu GS, Banerjee S, Lombardi WL.

The Retrograde Approach to Coronary Artery Chronic Total Occlusions: a Practical Approach. Catheter Cardiovasc Interv 2012;79:3-19 PMID: 22215566

3. Karmpaliotis D, Michael TT, Brilakis ES, Papayannis AC, Tran DL, Kirkland BL, Lembo N, Kalynych A,

Carlson H, Banerjee S, Lombardi WL, Kandzari DE. Retrograde Coronary Chronic Total Occlusion Revascularization: Procedural and In-Hospital Procedural Outcomes from a Multicenter Registry in the

United States. JACC Cardiovasc Interv 2012:5:1273-1279

4. Blankenship JC, Moussa I, Brilakis ES, Chambers C, Dehmer GJ, Morrison D. Staging of Multi-Vessel Percutaneous Coronary Interventions. Catheter Cardiovasc Interv 2012;79:1138-1152 PMID: 22072562

5. Martinez AA, Banerjee S, Brilakis ES. Knuckle wire and Stingray balloon for recrossing a coronary

dissection after loss of guidewire position. JACC Cardiovasc Interv 2012;5:e31-e32 PMID: 23078746

6. Whitlow PL, Lombardi WB, Wyman RM, Moses JW, Brilakis ES, Heuser RR, Rihal CS, Lansky AJ, Thompson CA. Use of a novel crossing and re-entry system in coronary chronic total occlusions that have failed standard crossing techniques: Results of the facilitated antegrade steering technique in chronic total occlusions (fast-ctos) trial. JACC Cardiovasc Interv 2012:5;393-401 PMID: 22516395



8

7. Banerjee S, Das TS, Abu-Fadel MS, Dippel EJ, Shammas NW, Tran DL, Zankar A, Varghese C, Kelly KC, Weideman RA, Little BB, Reilly RF, Addo T, Brilakis ES. Pilot trial of cryoplasty or conventional balloon post-dilation of nitinol stents for revascularization of peripheral arterial segments: The cobra trial. J Am Coll Cardiol. 2012;60:1352-1359 PMID: 22981558

8. Banerjee S, Master RG, Peltz M, Willis B, Mohammed A, Little BB, DiMaio MJ, Jessen ME, Brilakis ES.

Influence of chronic total occlusions on coronary artery bypass graft surgical outcomes. J Card Surg. 2012;27:662-7. PMID: 23173852

9. Hadidi OF, Mohammad A, Zankar A, Brilakis ES, Banerjee S. Embolic capture angioplasty in peripheral

artery interventions. J Endovasc Ther. 2012;19:611-616 PMID: 23046325

10. Banerjee S, Xu H, Fuh E, Nguyen KT, Garcia JA, Brilakis ES, Bhatt DL. Endothelial progenitor cell response to antiproliferative drug exposure. Atherosclerosis. 2012;225:91-98 PMID: 22959701

11. Xu H, Nguyen KT, Brilakis ES, Yang J, Fuh E, Banerjee S. Enhanced Endothelialization of a New Stent

Polymer Through Surface Enhancement and Incorporation of Growth Factor-Delivering Microparticles. J Cardiovasc Transl Res. 2012;5:519-527 PMID: 22639344

12. Brilakis ES, Karmpaliotis D, Patel V, Banerjee S. Complications of Chronic Total Occlusion Angioplasty.

Intervent Cardiol Clin 2012;1:373–389

13. Kampaliotis D, Lembo N, Brilakis ES, Kandzari D. Percutaneous Chronic Total Occlusion Revascularization. Program Development, Resource Utilization, and Economic Outcomes. Intervent Cardiol Clin 2012;1:391–395

14. Luna M, Banerjee S, Brilakis ES. Use of the CrossBoss catheter for crossing superficial femoral artery

chronic total occlusions. Cardiovasc Revasc Med. 2012;13;58-61 PMID: 21741325

15. Luna M, Papayannis A, Holper EM, Banerjee S, Brilakis ES. Transfemoral use of the guideliner catheter in complex coronary and bypass graft interventions. Catheter Cardiovasc Interv 2012;80:437-446 PMID: 21805572

16. Brilakis ES, Abdel-Karim AR, Papayannis AC, Michael TT, Rangan BV, Johnson JL, Banerjee S. Embolic

Protection Device Utilization During Stenting of Native Coronary Artery Lesions with Large Lipid Core Plaques As Detected By Near-Infrared Spectroscopy. Catheter Cardiovasc Interv 2012; 80:1157-62

17. Abdel-Karim AR, Papayannis AC, Mahmood A, Michael TT, Rangan BV, Makke L, Banerjee S, Brilakis

ES. Role of embolic protection devices in ostial saphenous vein graft lesions. Catheter Cardiovasc Interv 2012; 80:1120-6

18. Tolerico PH, Cohen DJ, Kleiman NS, Berger PB, Brilakis ES, Piana RN, Shammo S, Keyes MJ, Kennedy

KF, Massaro JM, Saucedo JF. In-hospital and one year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: A report from the event registry. Catheter Cardiovasc Interv 2012; 80:1127-36

19. Iturbe JM, Abdel-karim AR, Papayannis AC, Mahmood A, Rangan BV, Banerjee S, Brilakis ES. Frequency,

Treatment, and Consequences of Device Loss and Entrapment in Contemporary Percutaneous Coronary Interventions. J Invas Cardiol 2012;24:215-221 PMID: 22562915










9

20. Ramesh S, Papayannis A, Abdel-karim AR, Banerjee S, Brilakis ES. In Vivo comparison of Fourier-Domain Optical Coherence Tomography and Intravascular Ultrasonography. J Invas Cardiol 2012;24:111-5 PMID: 22388302

21. Pidlaoan V, Banerjee S, Brilakis ES. Application of Optical Coherence Tomography in the Treatment of Coronary Bifurcation Lesions. J Invas Cardiol 2011; 24:111-5 PMID: 22294547

22. Brayton K, Mohammad A, Brilakis ES, Banerjee S. An update on coronary artery chronic total occlusions.

Hosp Pract (Minneap). 2012;40:232-5 PMID: 22406899

23. Michael TT, Banerjee S, Brilakis ES. Distal “Open Sesame” and “Hairpin Wire” Techniques to Facilitate a Chronic Total Occlusion Intervention. J Invas Cardiol 2011; 24:E57-9 PMID: 22388317

24. Papayannis, A, Banerjee S, Brilakis ES. Use of the CrossBoss catheter in coronary chronic total occlusions

due to in-stent restenosis. Catheter Cardiovasc Interv 2012;80:E30-E36 PMID: 22162302

25. Mahmood A, Khair T, Abdel-karim AR, Papayannis AC, Xu H, Banerjee S, Brilakis ES. Embolic Protection Device Utilization in Saphenous Vein Graft Interventions: A Survey of 275 Interventional Cardiologists. Catheter Cardiovasc Interv 2012;79:834-842 PMID: 22511587

26. Papayannis AC, Michael TT, Yangirova D, Abdel-Karim AR, Kohlhaas J, Mahmood A, Addo T, Haagen

D, Makke L, Roesle M, Rangan BV, Banerjee S, Brilakis ES. Optical Coherence Tomography Analysis of the Stenting of Saphenous Vein Graft (SOS) Xience V Study: Use of the Everolimus-Eluting Stent in Saphenous Vein Graft Lesions. J Invas Cardiol 2012;24:390-394

27. Pu J, Mintz GS, Brilakis ES, Banerjee S, Abdel-Karim AR, Maini B, Biro S, Lisauskas JB, Lee JB, Guo J,

Shang Y, Sanidas E, Sum ST, Madden SP, Stone GW, Muller JE, Weisz G, Maehara A. In Vivo Tissue Characterization of Coronary Plaques: Novel Findings from Comparing Grayscale and Virtual Histology Intravascular Ultrasound and Near-Infrared Spectroscopy. Eur Heart J 2012: 33:372-83 PMID: 22019821

28. Michael TT, Banerjee S, Brilakis ES. Percutaneous Retrieval of a Fractured Guide Catheter Using

Contralateral Snaring. J Invas Cardiol 2012;24:E176-178 PMID: 22865321

29. Papayannis AC, Michael TT, Brilakis ES. Challenges Associated With Use of the Guideliner Catheter In Percutaneous Coronary Interventions. J Invas Cardiol 2012;24:370-371 PMID: 22781481

30. Michael TT, Banerjee S, Brilakis ES. Role of Internal Mammary Artery Bypass Grafts in Retrograde

Chronic Total Occlusion Interventions. J Invas Cardiol 2012;24:359-362 PMID: 22781479

31. Papayannis AC, Banerjee S, Brilakis ES. Retrograde wiring: a novel technique for identifying the origin of unusual saphenous vein grafts. Cardiovasc Revasc Med. 2012;13:298-300 PMID: 22898054

32. Greene RS, Rangel RM, Edwards KL, Chastain LM, Brouse SD, Alvarez CA, Collins LJ, Brilakis ES,

Banerjee S. Ranolazine for the treatment of refractory angina in a veterans population. Cardiovasc Revasc Med. 2012;13141.e1-5 PMID: 21856249

33. Mohammad A, Brilakis ES, Weideman RA, Little BB, Banerjee S. The Clinical Relevance of the

Clopidogrel-Proton Pump Inhibitor Interaction. J Cardiovasc Transl Res. 2012;5:547—552 PMID: 22351048








10

34. Jain N, Kotla S, Little BB, Weideman RA, Brilakis ES, Reilly RF, Banerjee S. Predictors of Hyperkalemia and Death in Patients With Cardiac and Renal Disease. Am J Cardiol 2012;109:1510-1513 PMID: 22342847

2011

1. Raghunathan D, Abdel-karim AR, Papayannis AC, daSilva M, Jeroudi O, Rangan BV, Banerjee S, Brilakis ES. Relation between the Presence and Extent of Coronary Lipid Core Plaques Detected by Near-Infrared Spectroscopy Following Percutaneous Coronary Intervention. Am J Cardiol 2011;107:1613-8 PMID: 21575750

2. Brilakis ES, Cohen DJ, Kleiman NS, Pencina J, Nassif D, Saucedo J, Piana RN, Banerjee S, Keyes MJ, Yen CH, Berger PB. Incidence and Clinical Outcome of Minor Surgery In the Year After Drug-Eluting Stent Implantation: Results from the EVENT Registry. Am Heart J 2011;161:360-366 PMID: 21315220

3. Lee MS, Park SJ, Kandzari DE, Kirtane A, Fearon W, Brilakis ES, Vermeersch P, Kim YH, Waksman R,

Mehilli J, Mauri L, Stone GW. Saphenous Vein Graft Intervention: State of the Art. J Am Coll Cardiol Intv 2011; 4: 831-843 PMID: 21851895

4. Goldstein JA, Maini B, Dixon SR, Brilakis ES, Grines CL, Rizik DG, Powers ER, Steinberg DH, Shunk KA, Weisz G, Moreno PR, Kini A, Sharma SK, Hendricks MJ, Sum ST, Madden SP, Mulluer JE, Stone GW, Kern MJ. Detection of Lipid-core Plaques by Intra-coronary Near-infrared Spectroscopy Identifies High Risk of Peri-Procedural Myocardial Infarction. Circ Cardiovasc Interv 2011; 4:429-437 PMID: 21972399

5. Gandhi NK, Abdel-karim AR, Banerjee S, Brilakis ES. Frequency and Risk of Noncardiac Surgery After

Drug-Eluting Stent Implantation. Catheter Cardiovasc Interv 2011;77:972-976 PMID: 20824750

6. Saeed B, Kandzari D, Agostoni P, Lombardi WL, Rangan BV, Banerjee S, Brilakis ES. Use of Drug-Eluting Stents for Chronic Total Occlusions: a Systematic Review and Meta-analysis. Catheter Cardiovasc Interv 2011;77:315-32 PMID: 20549695

7. Kandzari DE, Zankar AA, Teirstein PS, Brilakis ES, Banerjee S, Price MJ, Stinis CT, Hudson PA, Dahle

TG, Eng M, Brown R, Ferguson A, Addo TA, Popma JJ. Clinical outcomes following predilation with a novel 1.25-mm diameter angioplasty catheter. Catheter Cardiovasc Interv 2011;77:510-4 PMID: 21351225

8. Abdel-karim AR, Rangan BV, Banerjee S, Brilakis ES. Inter-Catheter Reproducibility of Near-Infrared Spectroscopy for the In-Vivo Detection of Coronary Lipid Core Coronary Plaques. Catheter Cardiovasc Interv 2011;12:170-6 PMID: 20824764

9. Michael TT, Abdel-karim AR, Papayannis AC, Lichtenwalter, C, de Lemos JA, Obel OO, Addo TA, Roesle M, Haagen D, Rangan BV, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger, PB, Banerjee S, Brilakis ES. Recurrent Cardiovascular Events with Paclitaxel-Eluting vs. with Bare-Metal Stents in Saphenous Vein Graft Lesions: Insights from the SOS (Stenting Of Saphenous vein grafts) Trial. J Invas Cardiol 2011; 23:216-9 PMID: 21646644

10. Banerjee S, Badhey N, Lichtenwalter C, Varghese C, Brilakis ES. Relationship of walking impairment and

ankle-brachial index assessments with peripheral arterial translesional pressure gradients. J Invas Cardiol. 2011;23:352-6. PMID: 21891803







11

11. Mahmood A, Banerjee S, Brilakis ES. Applications of the Distal Anchoring Technique in Coronary and Peripheral Interventions.J Invas Cardiol 2011;23:291-4. PMID: 21725125

12. Alshawabkeh LI, Banerjee S, Brilakis ES. Systematic Review of the Frequency and Outcomes of Non-

Cardiac Surgery after Drug-Eluting Stent Implantation. Hellenic J Cardiol; 2011;52:141-8 PMID: 21478124

13. Ball T, Banerjee S, Brilakis ES. Use of the venture catheter to shorten the door-to-balloon time in patients with ST-Segment elevation acute myocardial infarction. Cardiovasc Revasc Med. 2011;12:391-398 PMID: 21741323

14. Banerjee S, Iqbal A, Sun S, Master R, Brilakis ES. Peripheral embolic events during endovascular treatment of infra-inguinal chronic total occlusion. Cardiovasc Revasc Med 2011; 12:134.e7-10 PMID: 21195034

15. Khair T, Garcia B, Banerjee S, Brilakis ES. Contemporary Approaches to Perioperative Management of Coronary Stents and to Preoperative Coronary Revascularization: a Survey of 374 Interventional Cardiologists. Cardiovasc Revasc Med; 2011;12:99-104 PMID: 21421188

16. Zankar A, Brilakis ES, Banerjee S. Embolic capture angioplasty of lower extremity lesion following distal

embolization. Cardiovasc Revasc Med. 2011;12:337-40 PMID: 21616726

17. Banerjee S, Master R, Iqbal A, Brilakis ES. Stent medicati per interventi su graft di vena safena. Minerva Cardioangiol. 2011;59:235-8. PMID:

18. Abdel-karim AR, Gadiparthi C, Banerjee S, Brilakis ES. Catastrophic Left Main Coronary Artery Occlusion

Following Diagnostic Coronary Angiography: Salvage by Emergency Left Main Coronary Artery Stenting. Acute Card Care. 2011;13:170-3 PMID: 21517668

19. Banerjee S, Weideman RA, Weideman MW, Little BB, Kelly KC, Gunter JT, Tortorice KL, Shank M, Cryer B, Reilly RF, Rao SV, Kastrati A, de Lemos JA, Brilakis ES, Bhatt DL. Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention. Am J Cardiol 2011;107:871-8. PMID: 21247527

20. Michael TT, Badhey N, Banerjee S, Brilakis ES. Comparison of Characteristics and Outcomes of Saphenous Vein Graft Patients Who Were vs. Those Who Were Not Enrolled in the Stenting Of Saphenous Vein Grafts Randomized Controlled Trial. J Investig Med 2011;59:259-266 PMID: 21200334

21. Brilakis ES, Grantham JA, Banerjee S."Ping-pong" guide catheter technique for retrograde intervention of a

chronic total occlusion through an ipsilateral collateral. Catheter Cardiovasc Interv 2011;78:395-9 PMID: 21061243

22. Brilakis ES, Abdel-karim AR, Banerjee S. “Hairpin-trap”: a novel stent retrieval technique. Catheter Cardiovasc

Interv 2011;213-216 PMID: 20506275

23. Papayannis AC, Banerjee S, Brilakis ES Management of an unusual type of intra-aortic balloon pump dysfunction. J Invas Cardiol 2011; 23:390 PMID: 21891813

24. Moin D, Banerjee S, Brilakis ES. Occlusion of a Left Internal Mammary Artery Graft Side Branch During

Attempts to Deliver an Amplatzer Vascular Plug. J Invas Cardiol 2011;23:E229-31. PMID: 21972166

25. Brilakis ES, Badhey N, Banerjee S. “Bilateral Knuckle” Technique and Stingray Re-Entry System for Retrograde Chronic Total Occlusion Intervention. J Invas Cardiol 2011;23:E37-9 PMID: 21364245



http://www.ncbi.nlm.nih.gov/pubmed?term=%22Banerjee%20S%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Iqbal%20A%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Sun%20S%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Master%20R%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Brilakis%20ES%22%5BAuthor%5D








12

26. Mahmood A, Papayannis AC, Brilakis ES. Pro-arrhythmic Effects of Intracoronary Adenosine

Administration. Hellenic J Cardiol. 2011;52:352-3 PMID: 21933767

27. Michael TT, Banerjee S, Brilakis ES. Use of the Frontrunner Catheter to Cross a Chronic Total Occlusion of the Left Subclavian Artery. Hellenic J Cardio 2011;52:86-90 PMID: 21292613

28. Papayannis AC, Banerjee s, Brilakis ES. Multimodality Imaging of a Myocardial Infarction Culprit Lesion.

Hellenic J cardiol. 2011;52:536-7. PMID: 22143017

29. Jeroudi O, Abdel-Karim AR, Michael TT, Lichtenwalter C, de Lemos JA, Obel O, Addo TA, Roesle M, Haagen D, Rangan BV, Raghunathan D, DaSilva M, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger PB, Banerjee S, Brilakis ES. Paclitaxel-Eluting Stents Reduce Neointimal Hyperplasia Compared to Bare Metal Stent in Saphenous Vein Grafts: Results from the SOS (Stenting of Saphenous Vein Grafts) Trial. EuroIntervention 2011:7:948-954. PMID: 22157480

2010

1. Brilakis ES, Lasala JM, Cox DA, Berger PB, Bowman TS, Starzyk RM, Dawkins KD. Outcomes after

Implantation of the TAXUS Paclitaxel-Eluting Stent in Saphenous Vein Graft Lesions: Results from the ARRIVE Registries. J Am Coll Cardiol Intv 2010; 3:742-50

2. Wood FO, Badhey N, Garcia B, Abdel-karim AR, Maini B, Banerjee S, Brilakis ES. Analysis of Saphenous Vein Graft Lesion Composition Using Near-infrared spectroscopy and Intravascular Ultrasonography with Virtual Histology. Atherosclerosis 2010;212:528-533, PMID: 20673899

3. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lp-PLA(2) Studies Collaboration. Lancet. 2010;375:1536-44, PMID: 20435228

4. Banerjee S, Master R, Brilakis ES. Intravascular ultrasound-guided true lumen re-entry for successful recanalization of chronic total occlusions. J Invasive Cardiol. 2010;22:608-610. PMID: 21127367

Badhey N, Lichtenwalter, C, de Lemos JA, Roesle M, Obel OO, Addo TA, Haagen D, Abdel-karim, AR, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger, PB, Banerjee S, Brilakis ES. Contemporary Use of Embolic Protection Devices in Saphenous Vein Graft Interventions: Insights from the SOS (Stenting Of Saphenous vein grafts) Trial. Catheter Cardiovasc Interv 2010; 76:263-269. PMID: 20665875

5. Garcia BA, Wood F, Cipher D, Banerjee S, Brilakis ES. Reproducibility of Near-Infrared Spectroscopy for

the Detection of Lipid Core Coronary Plaques and Observed Changes After Coronary Stent Implantation. Catheter Cardiovasc Interv 2010;76:359–365, PMID: 20839348

6. Brilakis ES, Lombardi WL, Banerjee S. Use of the Stingray® Guidewire and the Venture® Catheter for Crossing Flush Coronary Chronic Total Occlusions due to In-Stent Restenosis. Catheter Cardiovasc Interv 2010; 76:391-4. PMID: 20839355

7. Iturbe JM, Abdel-karim AR, Raja VN, Rangan BV, Banerjee S, Brilakis ES. Use of the Venture Wire Control Catheter for the Treatment of Coronary Artery Chronic Total Occlusions. Catheter Cardiovasc Interv 2010;76:936-41, PMID: 20506266




http://www.ncbi.nlm.nih.gov/pubmed?term=%22Master%20R%22%5BAuthor%5D


13

8. Brilakis ES, Collins L, Obel, O, Banerjee S. Mechanical valve dysfunction after percutaneous perimitral leak

closure: salvage by percutaneous occluder retrieval. Catheter Cardiovasc Interv 2010; 75:876-81, PMID: 20146338

9. Badhey N, Lombardi WL, Thompson CA, Brilakis ES, Banerjee S. Use of the Venture™ Wire Control Catheter For Subintimal Coronary Dissection and Reentry in Chronic Total Occlusions. J Invas Cardiol 2010; 22:445–448, PMID: 20814054

10. Abdel-karim AR, Banerjee S, Brilakis ES. Percutaneous Intervention of Acutely Occluded Saphenous Vein Grafts: Contemporary Techniques and Outcomes. J Invas Cardiol 2010;22:253-7, PMID: 20516502

11. Abdel-karim AR, Lombardi WL, Banerjee S, Brilakis ES. Contemporary Outcomes of Percutaneous Intervention in Chronic Total Coronary Occlusions Due to In-Stent Restenosis. Cardiovasc Revasc Med 2010; 12:170-6. PMID: 21640935

12. Cooper L, Banerjee S, Brilakis ES Crossover from Radial to Femoral Access During a Challenging

Percutaneous Coronary Intervention Can Make The Difference Between Success and Failure. Cardiovasc Revasc Med 2010;11:266.e5-8, PMID: 20934669

13. Parikh SV, Parikh A, Brilakis ES, Banerjee S. Simultaneous dual coronary very late stent thrombosis following noncardiac surgery. Cardiovasc Revasc Med. 2010;11:172-4. PMID: 20599170

14. Brilakis ES, Saeed B, Banerjee S. Drug-eluting stents in saphenous vein graft interventions: a systematic review. Eurointervention 2010;5:722-730, PMID: 20142225

15. Testa L, Agostoni P, Vermeersch P, Biondi-Zoccai GG, van Gaal WJ, 3rdBhindi, R., Brilakis ES, Latini RA, Laudisa ML, Pizzocri S, Lanotte S, Brambilla N, Banning AP, Bedogni F. Drug eluting stent versus bare metal stent in the treatment of saphenous vein graft disease. A systematic review and meta-analysis. ΕuroIntervention 2010;6:527-536. PMID: 20884442

16. Saeed B, Banerjee S, Brilakis ES. Slow flow after Stenting of a Coronary Lesion with a Large Lipid Core

Plaque Detected by Near-Infrared Spectroscopy. EuroIntervention 2010: 2010;6:545. PMID: 20884445

17. Brilakis ES, Banerjee S. Management of patients with coronary stents in the ICU. Curr Opin Crit Care. 2010;16:426-31. PMID: 20736832

18. Raja VN, Banerjee S, Brilakis ES. Use of the Twin-Pass Catheter For Wiring a Jailed Side Branch. Hellenic J Cardiol 2010;51:267-270, PMID: 20515861

19. Meier P, Brilakis ES, Corti R, Knapp G, Shishenbor MH, Gurm HS. Drug-eluting versus bare-metal stent for treatment of saphenous vein grafts: a meta-analysis. PLoS One 2010;5:e11040. PMID: 20548794

20. Parikh SV, de Lemos JA, Jessen ME, Brilakis ES, Ohman EM, Chen AY, Wang TY, Peterson ED, Roe MT, Holper EM, CRUSADE obot, ACTION Registry-GWTG Participants. Timing of In-Hospital Coronary Artery Bypass Graft Surgery for Non-ST-Segment Elevation Myocardial Infarction Patients: Results From the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines). J Am Coll Cardiol Intv 2010;3:419-427, PMID: 20398870




14

21. Lichtenwalter C, Banerjee S, Brilakis ES. Dual guide catheter technique for treating native coronary artery lesions through tortuous internal mammary grafts: separating equipment delivery from target lesion visualization. J Invasive Cardiol 2010;22:E78-81, PMID: 20440050

22. Badhey N, Banerjee S, Brilakis ES. Amplatzer vascular plugs for occlusion of a left internal mammary artery

graft anastomosed to the anterior interventricular vein. Catheter Cardiovasc Interv;2010;75:742-7, PMID: 20091825

23. Luna M, Banerjee S, Brilakis ES. Closure of a Coexisting Ostium Secundum Atrial Septal Defect and Patent

Foramen Ovale Using a Single Amplatzer Patent Foramen Ovale Occluder Device. Cardiovasc Revasc Med 2010;11:63-66, PMID: 20129363

2009

1. Brilakis ES, Banerjee S, Lombardi WL. Retrograde recanalization of native coronary artery chronic occlusions via acutely occluded vein grafts. Catheter Cardiovasc Interv 2009; 75:109-113, PMID: 19670306

2. Brilakis ES, Lichtenwalter C, Banerjee S. "Armored" aspiration catheter technique to enhance aspiration

catheter delivery in challenging thrombus-containing lesions. Catheter Cardiovasc Interv 2009;74:846-849. PMID: 19496134

3. Brilakis ES, Banerjee S. Novel Uses of the Proxis Embolic Protection Catheter. Catheter Cardiovasc Interv

2009;74:438-445, PMID: 19496109

4. Banerjee S, Tony Das, Brilakis ES. Transcutaneous Ultrasound Guided Endovascular Crossing of Infra-inguinal Chronic Total Occlusions. Cardiovasc Revasc Med; 2010;11:116-9. PMID: 20347804

5. Brilakis ES, Banerjee S. Successful Retrograde Treatment of a Mid Left Anterior Descending Artery Chronic Total Occlusion Using a Novel “Guide Parallel to Wire” Technique. Catheter Cardiovasc Interv 2009;73:326-331, PMID: 19213087

6. Banerjee S, Brilakis ES, Das TS. Treatment of Complex Superficial Femoral Artery Lesions With PolarCath

Cryoplasty. Am J Cardiol 2009:104:447-449, PMID: 19616682

7. Banerjee S, Brilakis ES. Embolic Protection During Saphenous Vein Graft Interventions. J Invas Cardiol 2009; 21:415-417, PMID: 19652257

8. Boatman D, Saeed B, Varghese I, Peters CT, Daye J, Haider A, Roesle M, Banerjee S, Brilakis ES. Prior

coronary artery bypass graft surgery patients undergoing diagnostic coronary angiography have multiple uncontrolled coronary artery disease risk factors and high risk for cardiovascular events. Heart Vessels 2009;24:241-246, PMID: 19626394

9. Michael, TT, Banerjee S Brilakis ES,. Subclavian Artery Intervention with Vertebral Embolic Protection.

Catheter Cardiovasc Interv 2009;74:22-25, PMID: 19530179

10. Banerjee S, Brilakis ES. Use of the Proxis embolic protection device for guide anchoring and stent delivery during complex saphenous vein graft interventions. Cardiovasc Revasc Med 2009;10:183-187, PMID: 19595401

15

11. Varghese, I, Samuel J, Banerjee S, Brilakis ES. Comparison of Percutaneous Coronary Intervention in Native Coronary Arteries vs. Bypass Grafts in Prior Coronary Artery Bypass Graft Surgery Patients. Cardiovasc Revasc Med; 2009;10:103-109, PMID: 19327672

12. Dimas B, Lindsey JB, Banerjee S, Brilakis ES. ST-segment Elevation Acute Myocardial infarction Due To

Severe Hypotension and Proximal Left Subclavian Artery Stenosis in a Prior Coronary Artery Bypass Graft Patient. Cardiovasc Revasc Med 2009;10:191-194, PMID: 19595403

13. Tsimikas S, Clopton P, Brilakis ES, Marcovina SM, Khera A, Miller ER, de Lemos JA, Witztum JL.

Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study. Circulation. 2009;119:1711-9. PMID: 19307470

14. Prasad A, Prasad A, Varghese I, Roesle M, Banerjee S, Brilakis ES. Prevalence and treatment of proximal

left subclavian artery stenosis in patients referred for coronary artery bypass surgery. Int J Cardiol 2009;133:109-111. PMID: 18158191

2008

1. Brilakis ES, de Lemos JA, Cannon CP, Wiviott SD, Murphy SA, Morrow DA, Sabatine MS, Banerjee S, Blazing MA, Califf RM, Braunwald E. Outcomes of Patients With Acute Coronary Syndrome and Prior Coronary Artery Bypass Grafting. Results (From the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE-IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials). Am J Cardiol 2008;102:552-558, PMID: 18721511

2. Varghese I, Boatman DM, Peters CT, Daye J, Haider A, Roesle M, Banerjee S, Brilakis ES. Impact on Contrast, Fluoroscopy, and Catheter Utilization From Knowing the Coronary Artery Bypass Graft Anatomy Before Diagnostic Coronary Angiography. Am J Cardiol 2008; 101:1729-1732, PMID: 18549848

3. Saeed B, Banerjee S, Brilakis ES. Percutaneous coronary intervention in tortuous coronary arteries: associated complications and strategies to improve success. J Interv Cardiol 2008;21:504-511, PMID: 18705640

4. Brilakis ES, Khera A, Saeed, B, , Banerjee S , McGuire DK, Murphy SA, de Lemos JA. Association of

Lipoprotein-Associated Phospholipase A2 Mass and Activity with Coronary and Aortic Atherosclerosis: Findings From the Dallas Heart Study. Clin Chemistry 2008;54:1975-1981, PMID: 18832472

5. Brilakis ES, Khera A, McGuire DK, See R, Banerjee S, Murphy SA, de Lemos JA. Influence of Race and

Sex on Lipoprotein-Associated Phospholipase A2 Levels: Observations from the Dallas Heart Study. Atherosclerosis 2008;199:110-115. PMID: 18061193

6. Banerjee S, Varghese C, Samuel J, Weideman RA, Little BB, Kelly KC, Rao SV, Reily RF, Brilakis ES. Prolonged Clopidogrel Use Following Percutaneous Coronary Intervention is Associated with Lower Mortality. Am J Cardiol 2008;102:1159-62. PMID: 18940284

7. Banerjee S, Compton PA, Hooker RS, Cipher DJ, Reimold A, Brilakis ES, Banerjee P, Kazi

S.Cardiovascular Outcomes in Male Veterans with Rheumatoid Arthritis (COVARA). Am J Cardiol; 2008;101:1201-1205, PMID: 18394459

16

8. Brilakis ES, Banerjee S. The “Proxis-Tornus” technique for a difficult to cross calcified saphenous vein graft lesion. J Invasive Cardiol 2008;20:E258-61, PMID: 18762683

9. Haider A, Banerjee S, Brilakis ES. Acute Pulmonary Edema due to Pacemaker-Induced Mitral

Regurgitation. J Invasive Cardiol; 2008;20:E84, PMID: 18316840

10. Warner JJ, Weideman RA, Kelly KC, Brilakis ES, Banerjee S, Cunningham F, Harford WV, Kazi S, Little BB, Cryer B. The Risk of Acute Myocardial Infarction With Etodolac is Not Increased Compared to Naproxen: A Historical Cohort Analysis of a Generic COX-2 Selective Inhibitor. Journal of Cardiovascular Pharmacology and Therapeutics 2008:1074248408323136. PMID: 18787084

11. Brilakis ES, Brilakis HS. Pursuing Postgraduate Training in Internal Medicine and Cardiology in the USA:

An Introduction for Greek Physicians. Hellenic J Cardiol 2008; 49: 222-226, PMID: 18935708

12. Daye J, Boatman D, Peters C, Varghese I, Haider A, Roesle M, Jessen ME, DiMaio JM, Banerjee S, Brilakis ES. Perioperative Risk of Patients Undergoing Noncardiac Surgery After Coronary Artery Bypass Surgery. J Investig Med 2008;56:878-881, PMID: 18667906

13. Varghese I, Ummer A, Roesle M, Banerjee S, Brilakis ES. Recurrent late drug-eluting stent thrombosis upon

discontinuation of antiplatelet therapy. Cardiovasc Revasc Med 2008;9:179-181, PMID: 18606381

14. Brilakis ES, Saeed, B, Banerjee S. Use of Drug-Eluting Stents in Saphenous Vein Aortocoronary Bypass Graft Lesions: a Critical Appraisal. J Interv Cardiol 2008;21:151-157, PMID: 18312303

15. Prasad A, Compton PA, Prasad A, Roesle M, Makke L, Rogers S, Banerjee S, Brilakis ES. Incidence and

treatment of arterial access dissections occurring during cardiac catheterization. J Interv Cardiol 2008;21:61-66, PMID: 18254788

16. Prasad A, Cipher DJ, Prasad A, Mohandas A, Roesle M, Brilakis ES, Banerjee S. Reproducibility of

Intravascular Ultrasound Virtual Histology Analysis. Cardiovasc Revasc Med 2008;9:71-77, PMID: 18486080

17. Lindsey JB, Brilakis ES, Banerjee S. Extrinsic Compression of the Left Main Coronary Artery Treated with Percutaneous Coronary Intervention. A Case Report and Review of the Literature. Cardiovasc Revasc Med 2008;9:47-51. PMID: 18206638

2007

1. Lindsey JB, Banerjee S, Brilakis ES. Two “buddies” may be better than one: use of two buddy wires to expand an under-expanded left main coronary stent. J Invasive Cardiol 2007;19:E355-358, PMID: 18180526

2. Brilakis ES, Banerjee S, Berger PB. Perioperative management of coronary stents. J Am Coll Cardiol

2007;49:2145-50, PMID: 17543633

3. Brilakis ES, Banerjee S, Berger PB. The risk of drug-eluting stent thrombosis with noncardiac surgery. Curr Cardiol Rep 2007;9:406-11, PMID: 17877936

4. Iturbe JM, Banerjee S, Brilakis ES. Exertional dyspnea due to spontaneous coronary artery dissection in a

55-year-man. Heart 2007;93:1212, PMID: 17890697

17

5. The Lp-PLA2 Studies Collaboration; Ballantyne C, Cushman M, Psaty B, Furberg C, Khaw KT, Sandhu M, Oldgren J, Rossi GP, Maiolino G, Cesari M, Lenzini L, James SK, Rimm E, Collins R, Anderson J, Koenig W, Brenner H, Rothenbacher D, Berglund G, Persson M, Berger P, Brilakis E, McConnell JP, Koenig W, Sacco R, Elkind M, Talmud P, Rimm E, Cannon CP, Packard C, Barrett-Connor E, Hofman A, Kardys I, Witteman JC, Criqui M, Corsetti JP, Rainwater DL, Moss AJ, Robins S, Bloomfield H, Collins D, Packard C, Wassertheil-Smoller S, Ridker P, Ballantyne C, Cannon CP, Cushman M, Danesh J, Gu D, Hofman A, Nelson JJ, Thompson S, Zalewski A, Zariffa N, Di Angelantonio E, Kaptoge S, Thompson A, Thompson S, Walker M, Watson S, Wood A. Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases. Eur J Cardiovasc Prev Rehabil 2007;14:3-11, PMID: 17301621

6. Wolk R, Berger PB, Lennon RJ, Brilakis ES, Davison DE, Somers VK. Association between plasma adiponectin levels and unstable coronary syndromes. Eur Heart J 2007;28:292-8, PMID: 17090613

7. Brilakis ES, Roesle M, Banerjee S. Stent Deformation after Catheter Advancement through a Recently Deployed Self-Expanding Stent: Diagnosis, Mechanism and Correction. J Invasive Cardiol 2007:19:46, PMID: 17297186

8. Banerjee S, Cho M, Gupta S, Brilakis ES. Aberrant Takeoff of a Right Accessory Renal Artery Identified during an Aortoiliac Intervention. Vasc Dis Management 2007;4:4-5.

9. Tsimikas S, Brilakis ES, Lennon RJ, Miller ER, Witztum JL, McConnell JP, Kornman KS, Berger PB.

Relationship of IgM and IgG autoantibodies to oxidized low density lipoprotein and apolipoprotein B100-immune complexes with angiographically determined coronary artery disease and cardiovascular events. J Lip Res 2007;48:425-433, PMID: 17093289

10. Prasad A, Banerjee S, Brilakis ES. Hemodynamic consequences of massive coronary air embolism.

Circulation 2007;115:e51-3. PMID: 17261666

2006 and prior

1. Compton PA, Zankar AA, Adesanya AO, Banerjee S, Brilakis ES. Risk of Non-Cardiac Surgery After Coronary Drug-Eluting Stent Implantation. Am J Cardiol 2006 ;98:1212-3, PMID: 17056330

2. Yang EH, Brilakis ES, Reeder GS, Gersh BJ. Modern management of acute myocardial infarction. Curr Probl Cardiol 2006,31:769-817, PMID: 17097446

3. Banerjee S, Brilakis E, Zhang S, Roesle M, Lindsey J, Philips B, Blewett CG, Terada LS. Endothelial

progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis 2006,89:70-5, PMID: 16806234

4. Williams BA, Wright RS, Murphy JG, Brilakis ES, Reeder GS, Jaffe AS. A new simplified immediate

prognostic risk score for patients with acute myocardial infarction. Emerg Med J 2006; 23: 186 – 192, PMID: 16498154

5. Brilakis ES, Best PJM, Elesber AA, Barsness GW, Lennon RJ, Holmes DR Jr, Rihal CS, Garratt KN. PB.

Incidence, Retrieval Methods, and Outcomes of Stent Loss During Percutaneous Coronary Intervention: A Large Single Center Experience. Catheter Cardiovasc Interv 2005;66:333-340, PMID: 16142808

18

6. Brilakis ES, Orford JL, Fasseas P, Wilson SH, Melby S, Lennon RJ, Berger PB. Clinical Outcome of Patients Undergoing Balloon Angioplasty vs. Stent Placement in the Two Months Prior to Non-Cardiac Surgery. Am J Cardiol 2005;96:512-4, PMID: 16098302

7. Brilakis ES, Friedman PA, Maounis TN, Rokas SG, Shen WK, Stamatelopoulos SF, Cokkinos DV.

Programmed Ventricular Stimulation in Patients with Idiopathic Dilated Cardiomyopathy and Syncope Receiving Implantable Cardioverter-Defibrillators: A Case Series and A Systematic Review of the Literature. Int J Cardiol 2005;98:395-401, PMID: 15708170

8. Wolk R, Berger P, Lennon RJ, Brilakis ES, Johnson BD, Somers VK. Plasma leptin level and prognosis in

patients with established coronary atherosclerosis. J Am Coll Cardiol 2004;44:1819-24, PMID: 15519013

9. Brilakis ES, Maniu CV, Wahl MR, Barsness GW. Unstable angina due to stent fracture. J Invasive Cardiol 2004:16:545, PMID: 15353819

10. Brilakis ES, Nishimura RA. Dynamic respiratory changes in hypertrophic cardiomyopathy; Heart

2004;90:296, PMID: 14966051

11. Brilakis ES, Wright RS, Kopecky SL, Mavrogiorgos NC, Reeder, GS, Gersh BJ, Williams BA, Clements IP. Association of the PURSUIT risk score with predischarge ejection fraction, angiographic severity of coronary artery disease, and mortality in a nonselected, community-based population with non-ST elevation acute myocardial infarction; Am Heart J 2003;146:811-8, PMID: 14597929

12. Al-Ahmari S, Chandrasekaran K, Brilakas E, Tahlil W, Dearani J, Malouf J, Gilman G, Seward JB, Tajik AJ

Isolated partial anomalous pulmonary venous connection: Diagnostic value of suprasternal color flow imaging and contrast echocardiography. J Am Soc Echocardiogr 2003;6:884-9. PMID:12878999

13. Work R, Berger PB, Lennon RJ, Brilakis ES, Somers VK. Body mass index. A risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Cicrulation 2003;108:2206-11, PMID: 14557360

14. Brilakis ES, Reeder GS, Gersh BJ. Modern management of acute myocardial infarction. Curr Probl Cardiol

2003;28:7-127. PMID: 12598875

15. Brilakis ES, Nishimura RA. Severe Pulmonary Hypertension in a Patient with Hypertrophic Cardiomyopathy: Response to Alcohol Septal Ablation; Heart 2003;89:790. PMID: 12807862

16. Brilakis ES, Berger PB, Ballman KV, Rozen R. Methylenetetrahydrofolate reductase (MTHFR) C677T and

methionine synthase reductase (MTRR) A66G polymorphisms: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid; Atherosclerosis 2003;168:315-22. PMID: 12801615

17. Brilakis ES, McConnell JP, Ballman KV, Klee GG, Berger PB. Lack of association between plasma

homocysteine and angiographic coronary artery disease in the era of folic acid fortified cereal grain flour; Atherosclerosis 2002;165:375-381. PMID: 12417290

18. Brilakis ES, Mavrogiorgos NC, Kopecky SL, Wright RS, Reeder, GS, Gersh BJ, Williams BA, Clements IP.

Usefulness of QRS duration in the absence of bundle branch block as an early predictor of survival in non-ST elevation acute myocardial infarction; Am J Cardiol 2002;89:1013-18. PMID: 11988187

19

19. Fasseas P, Brilakis ES, Leybishkis B, Cohen M, Sokil AB, Wolf N, Dorn RL, Roberts A, VanDecker W. Association of carotid artery intima-media thickness with complex aortic atherosclerosis in patients with recent stroke. Angiology 2002;53:185-9. PMID: 11952109

20. Hassan I, Brilakis ES, Thompson RL, Que FG. Surgical management of abdominal tuberculosis; J

Gastrointest Surg. 2002;6:862-7. PMID: 12504225

21. Brilakis ES, Shen WK, Hammill SC, Hodge DO, Rea RF, Lexvold, NY, Friedman PA. Role of programmed ventricular stimulation and implantable cardioverter-defibrillators in patients with idiopathic dilated cardiomyopathy and syncope. PACE 2001;24:1623-30. PMID: 11816631

22. Brilakis ES, Wright RS, Kopecky SL, Reeder GS, Williams BA, Miller WA. Bundle-branch block as a predictor of long-term survival after acute myocardial infarction. Am J Cardiol 2001;88:205-9. PMID: 11472694

23. Brilakis ES, Manginas AN, Cokkinos DV. Chronic thromboembolic pulmonary hypertension in a patient heterozygous for both factor V Leiden and the G20120A prothrombin mutation. Heart 2001;86:149. PMID: 11454828

24. Brilakis ES, Olson LJ, Berry GR, Daly RC, Loisance D, Zucker M, Cooper LT. Survival outcomes of

patients with giant-cell myocarditis bridged by ventricular assist devices; ASAIO J 2000;46:569-572. PMID: 11016508

25. Brilakis ES, Olson EJ, McGregor CGA, Olson LJ. Sleep apnea in heart transplant recipients: type,

symptoms, risk factors, and response to nasal continuous positive airway pressure. J Heart Lung Transplant 2000;19:330-6. PMID: 10775812

26. Brilakis ES, Wolfe ME, Brilakis HS, Friedman PA. Wide QRS tachycardia refractory to pharmacologic

interventions and cardioversion. Am J Emerg Med 2000;18:453-456. PMID: 10919538

27. Brilakis ES, Young WF Jr, Wilson JW, Thompson GB, Munger TM. Reversible catecholamine-induced cardiomyopathy in a heart transplant candidate without persistent or paroxysmal hypertension. J Heart Lung Transplant 1999;18:376-80, PMID: 10226904

28. Brilakis ES, Tajik AJ. 82-year-old man with recurrent syncope. Mayo Clin Proc 1999;74:609-12. PMID:

10377938

BOOK CHAPTERS 1. Brilakis ES, He Z, Sum ST, Madden SP, Muller JE. Imaging Coronary Atherosclerosis, edited by Drs. Stephen J.

Nicholls & Timothy Crowe. Humana Press, 2012 (in press)

2. Brilakis ES. Saphenous vein graft interventions. Clinical Decision Support in Medicine. Editors: Drs.

Greenberg, Bhatt, Boden, Carabello, and Naccarelli. 2012, in press

3. Brilakis ES, Banerjee S. Bypass Graft Intervention and Embolic Protection SCAI Interventional Cardiology Review Book, 2nd edition , 2012 (in press)

4. Brilakis ES, Banerjee S. Percutaneous coronary intervention in the elderly. Textbook of Cardiovascular Intervention, Springer Science, New York, 2011 (in press)

20

5. Brilakis ES, He Z, Sum ST, Madden SP, Muller JE. Imaging of Structure and Composition of Lipid Core Plaque

with a Combination NIRS-IVUS System: Current Status and Potential Clinical Applications. Coronary Atherosclerosis: Current Management and Treatment 1st edition, Informa Healthcare, London 2011

6. Brilakis ES, Banerjee S. Mechanical Complications of Acute Myocardial Infarction. ACC Self Assessment

Program 8th edition 2011.

7. Brilakis ES, Banerjee S. Vein Graft Lesions. Nova Science Publishers, 2011

8. Brilakis ES, Sum ST, Madden SP, Muller JE. In Michalis L, Fotiadis D, Naka K, Couranta C, Tsakanikas V (editors). Intravascular Imaging of Lipid Core Plaque by Near-Infrared Spectroscopy. Intravascular Imaging: Current Applications and Research Developments, Global – IGI, 2011

9. Brilakis ES, Berger PB: Management of a patient with a drug eluting stent, in Braunwald's Heart Disease e-Dition, www.expertconsultbook.com. Philadelphia: Elsevier, 2008.

10. Brilakis ES, Banerjee S. Mechanical Complications of Acute Myocardial Infarction. ACC Self Assessment

Program 7th edition 2008. 11. Brilakis ES, Garrat KN. Device loss during percutaneous coronary intervention: incidence, complications, and

retrieval methods. In Ellis S, Holmes DR (editors), In Ellis S, Holmes DR (editors), Strategic Approaches in Coronary Intervention, Lippincott Williams & Wilkins, 2005

12. Brilakis ES, Rihal CS. The thrombus containing lesion. In Ellis S, Holmes DR (editors), In Ellis S, Holmes DR (editors), Strategic Approaches in Coronary Intervention, Lippincott Williams & Wilkins, 2005

13. Garrat KN, Brilakis ES, Bacharach SM. Stent retrieval: devices and technique. In Heuser RR, Henry M (editors).

Peripheral Vascular Stenting, Martin Dunitz Ltd, 2004 EDITORIALS 1. Brilakis ES, Banerjee S. Perioperative Management of Drug-Eluting Stents: the Achilles Heel of Bridging.

Catheter Cardiovasc Interv. 2013;in press 2. Latif F, Brilakis ES. Ready for anything: the value of anticipation, prevention and early treatment of

complications during chronic total occlusion interventions. Catheter Cardiovasc Interv. 2013;in press

3. Brilakis ES, Banerjee S. Patient with coronary stents needs surgery: what to do? JAMA 2013;310;1451-1452.

4. Patel VG, Brilakis ES. Launching Into Orbit: First In Man Use of a Novel Coronary Atherectomy Device. Catheter Cardiovasc Interv. 2013;81:1140-1

5. Banerjee S, Sarode K, Brilakis ES. Protected PTA in the lower limbs: a step forward in preventing distal embolization. J Endovasc Ther 2013;published online before print

6. Brilakis ES, Banerjee A. Change or die! J Invasive Cardiol. 2013; 25:165

http://www.expertconsultbook.com/


21

7. Garcia S, Brilakis ES. Optimal stenting strategy for coronary chronic total occlusion interventions: what is next?

Catheter Cardiovasc Interv. 2013;81:800-1.

8. Bagai J, Brilakis ES. Preclosing large venous sheaths with perclose can facilitate advanced structural heart interventions. Catheter Cardiovasc Interv. 2013;81:591

9. Singla S, Brilakis ES. “Bad things happen in threes”: a story of saphenous vein graft failure, stent fracture, and stent loss. Catheter Cardiovasc Interv. 2013;81:66-7

10. Banerjee S, Garg P, Brilakis ES. Commentary: embolic capture angioplasty with the 300-mm-long proteus balloon. J Endovasc Ther. 2012;19:834-5

11. Alaswad K, Brilakis ES. How treating a chronic total occlusion affirms that "necessity is the mother of all

inventions". Catheter Cardiovasc Interv. 2012;80:619-620

12. Brilakis ES, Patel V. What you can’t see can hurt you! J Invasive Cardiol. 2012;24:421

13. Klein AJ, Brilakis ES. Less may be more: insights on dual antiplatelet therapy duration after drug-eluting stent implantation from the MATRIX registry. Catheter Cardiovasc Interv. 2012;80:417-419

14. Maniu CV, Brilakis ES. Unprotected left main disease: surgery, stents or both?. Catheter Cardiovasc Interv.

2012;80:245-6

15. Brilakis ES, Banerjee S. Saphenous Vein Graft Interventions: Drug-Eluting Stents are Better and Safe but not Good Enough. Catheter Cardiovasc Interv. 2012;79:910-911

16. Brilakis ES, Banerjee S. Dancing with the “STAR”: the Role of Subintimal Dissection/re-entry Strategies in Coronary Chronic Total Occlusion Interventions. Catheter Cardiovasc Interv. 2012;79:28-29

17. de Lemos JA, Brilakis ES. No Free Lunches: Balancing Bleeding and Efficacy With Ticagrelor. Eur Heart J 2011;32:2919-2921

18. Papayannis AC, Brilakis ES. Stent fracture: broken stents-broken hearts. Catheter Cardiovasc Interv. 2011;78:1107-1107

19. Michael T, Brilakis ES. Taming Saphenous Vein Grafts Using Guide Catheter Extensions. Catheter Cardiovasc

Interv. 2011; 78:864–865 20. Rangan BV, Brilakis ES. Getting out of jail: Creative solutions in a moment of crisis. Catheter Cardiovasc

Interv. 2011;78:571-2

21. Brilakis ES, Banerjee S. Crossing the "balloon uncrossable" chronic total occlusion: Tornus to the rescue. Catheter Cardiovasc Interv. 2011;78:363-5

22. Brilakis ES, Banerjee S. What can we do for patients undergoing saphenous vein graft interventions? Catheter Cardiovasc Interv 2011;78:30-31

23. Brilakis ES, Banerjee S. Advances in the Treatment of Coronary Artery Aneurysms. Catheter Cardiovasc Interv 2011;77:1042-1044





22

24. Varshney A, Martinez-Rumayor AA, Brilakis ES, Banerjee S. Cardiac MRI Evaluation of Infarct Size with

Thrombus Aspiration During ST-Segment Elevation Myocardial Infarction. J Invasive Cardiol. 2011;23:177-8 25. Banerjee S, Iqbal A, Brilakis ES. Optical coherence tomography-guided percutaneous coronary interventions. J

Invasive Cardiol 2010;22:546-7

26. Banerjee S, Thatthi T, Badhey N, Brilakis ES. Atheroemboli during peripheral arterial interventions. J Invasive Cardiol. 2009;21:632-3

27. Brilakis ES, Berger PB. Should Bare Metal or Drug-Eluting Stents Be Used During PCI of Saphenous Vein Graft Lesions: Waiting For Godot? Catheter Cardiovasc Interv 2008;72:815-818

28. Brilakis ES, Berger PB. Treatment of coronary bifurcation lesions: might less be more? Eur Heart J 2008;29:704-706

LETTERS TO THE EDITOR

1. Brilakis ES, Banerjee S, Shunk KA, Bhatt DL. Correspondence regarding manuscript: “Mehilli J, Pache J, Abdel-Wahab M, et al. Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial. Lancet 2012; 379:615

2. Brilakis ES, Banerjee S. Intracoronary adenosine administration in the right coronary artery: a word of caution. JACC Cardiovasc Interv. 2012; 5:245

3. Brilakis ES, Rao SV, Banerjee S, Goldman S, Shunk KA, Holmes DR Jr, Honeycutt E, Roe MT. Reply to “Percutaneous Coronary Interventions Following Coronary Artery Bypass Graft: In-Hospital Mortality and Long-Term Follow-Up”. JACC Cardiovasc Interv. 2011;4:1252.

4. Lee MS, Park SJ, Kandzari DE, Kirtane AJ, Fearon WF, Brilakis ES, Vermeersch P, Kim YH, Waksman R, Mehilli J, Mauri L, Stone GW. Reply to letter: Saphenous Vein Graft Intervention: Discussion on Acute Vein Graft Occlusion Intervention. JACC Cardiovasc Interv. 2011;4:1250-1

5. Badhey N, Banerjee S, Brilakis ES. Rebuttal: innovative embolic protection strategies for saphenous vein graft interventions. Catheter Cardiovasc Interv. 2011;77:595

6. Badhey N, Banerjee S, Brilakis ES. Use of embolic protection devices in saphenous vein graft interventions: The ongoing challenge. Catheter Cardiovasc Interv 2010;epub ahead of print

7. Brilakis ES, Banerjee S. Could Paclitaxel-Eluting Stents Be Superior to Sirolimus-Eluting Stents for the Treatment of Saphenous Vein Graft Lesions? Am J Cardiol 2010;106:1367-8

8. Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, Saeed B, Gadiparthi C, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S. The SOS acronym. J Am Coll Cardiol. 2009;54:2338-2339

9. Brilakis ES, Banerjee S. Letter by Brilakis and Banerjee regarding article, "Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft". Circulation. 2006;114:e648

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Varshney%20A%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Martinez-Rumayor%20AA%22%5BAuthor%5D






http://www.sciencedirect.com/science/article/pii/S1936879811006881?_rdoc=1&_fmt=high&_origin=browse&_docanchor=&_ct=1&_refLink=Y&_zone=rslt_list_item&md5=406b33983eca14600acb3034a362ff96

http://www.sciencedirect.com/science/article/pii/S1936879811006881?_rdoc=1&_fmt=high&_origin=browse&_docanchor=&_ct=1&_refLink=Y&_zone=rslt_list_item&md5=406b33983eca14600acb3034a362ff96

http://www.sciencedirect.com/science/article/pii/S193687981100687X?_rdoc=1&_fmt=high&_origin=browse&_docanchor=&_ct=1&_refLink=Y&_zone=rslt_list_item&md5=406b33983eca14600acb3034a362ff96

http://www.sciencedirect.com/science/article/pii/S193687981100687X?_rdoc=1&_fmt=high&_origin=browse&_docanchor=&_ct=1&_refLink=Y&_zone=rslt_list_item&md5=406b33983eca14600acb3034a362ff96





http://www.ncbi.nlm.nih.gov/pubmed?term=%22Brilakis%20ES%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Lichtenwalter%20C%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22de%20Lemos%20JA%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Roesle%20M%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Obel%20O%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Haagen%20D%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Saeed%20B%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Gadiparthi%20C%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Bissett%20JK%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Sachdeva%20R%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Voudris%20VV%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Karyofillis%20P%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Kar%20B%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Rossen%20J%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Fasseas%20P%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Berger%20P%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Banerjee%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Banerjee%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract

23

10. Brilakis ES. Risk of surgery after coronary stent placement. Letter to the editor. British Journal of Anaesthesia. 2006. http://bja.oxfordjournals.org/cgi/eletters/96/6/686

11. Brilakis ES, Banerjee S. Continuation of clopidogrel may be safe during bronchoscopy with biopsy. Letter to the editor. Chest 2006. http://www.chestjournal.org/cgi/eletters/129/3/734

12. Brilakis ES, Kopecky SL, Wright RS, Reeder GS, Williams BA, Clements IP. Evaluation of the EMMACE model in a US population with non-ST elevation acute myocardial infarction. Heart 2001;http://heart.bmjjournals.com/cgi/eletters/86/2/150

13. Brilakis ES, Friedman PA, Gersh BJ, Shen WK. Oral amiodarone and atrial fibrillation. Lancet 2001;358:147-8

INVITED PRESENTATIONS

1. Periprocedural bleeding (aka what’s the big deal): incidence and risk. STEMI Texas 2013, San Antonio, Texas

2. Assessing Quality in the Cath Lab: Innovation from the US Veterans Health Administration. New Clinical Programs: CTO. TCT 2013, San Francisco, California

3. Identifying and Managing Embolic-Prone Lesions: RF-IVUS, OCT, and NIRS. TCT 2013, San Francisco, California

4. Is dissection reentry technique a predictor of CTO reocclusion? EuroCTO Club, Paris, France, September 28, 2013

5. Get the Vessel Open Quick! True Lumen vs. Subintimal Entry Does Not Matter: A North American Model. Complex Cardiovascular Catheter Therapeutics, Orlando, Florida, June 19, 2013

6. Coronary CTOs: Βreaking the “last frontier”. 11th International Cardiology Congress, Patras, Greece, May 18, 2013

7. CTO: Retrograde State-Of-The Art overview. Concepts in Contermporary Cardiovascular Medicine Symposium. Houston, Texas, April 3, 2013

8. My top 5 tips and tricks on saphenous vein graft intervention. American College of Cardiology Scientific Sessions, San Francisco, March 2013

9. My top 5 tips and tricks on the balloon uncrossable chronic total occlusion. American College of Cardiology Scientific Sessions, San Francisco, March 2013

10. Optical coherence tomography: clinically relevant or still hoping? American College of Cardiology Scientific Sessions, San Francisco, March 2013

11. Perioperative management of coronary stents. American Heart Association Scientific Sessions, Los Angeles, California, November 2012

12. Interventional Pharmacology: Acute Coronary Syndromes/NSTEMI. TCT, Miami, Florida, October 2012 13. Thrombectomy and Distal Protection in Native Coronary Artery and Saphenous Vein Graft Lesions. TCT,

Miami, Florida, October 2012 14. The CTO Toolkit: What Do I Need in the Lab? TCT, Miami, Florida, October 2012 15. Cardiology Grand Rounds. University of Texas San Antonio, San Antonio, Texas. “Coronary Chronic Total

Occlusion Interventions: state of the art 2012” 16. Visiting Professor. LeHigh Valley Health Network, Allentown, Pennsylvania. “Improving Saphenous Vein

Graft Patency” and “How to Write a Scientific Paper”. October 5, 2012. 17. Near-infrared spectroscopy. Invasive and Non-Invasive Imaging of Coronary Artery Disease. Corfu Greece,

June 30, 2012. 18. Taped case presentation: Multivessel PCI – imaging and physiology. American College of Cardiology

Annual Scientific Sessions, Chicago, Illinois, March 24, 2012

http://bja.oxfordjournals.org/cgi/eletters/96/6/686

http://www.chestjournal.org/cgi/eletters/129/3/734

24

19. Distal Embolization during PCI: Predicting Distal Embolization Using Grayscale IVUS, RF-IVUS, OCT, and NIRS. American College of Cardiology Annual Scientific Sessions, Chicago, Illinois, March 24, 2012

20. Establishing a Cardiac Catheterization Imaging/Physiology Program: Optical Coherence Tomography and Near-Infrared Spectroscopy. American College of Cardiology Annual Scientific Sessions, Chicago, Illinois, March 24, 2012

21. PCI in ACS and Non-STEMI: Guidelines and Outcomes. TCT, San Francisco, California, November 2011 22. Interventional Pharmacology: Acute Coronary Syndromes/NSTEMI. TCT, San Francisco, California,

November 2011 23. Thrombectomy and Distal Protection in Native Coronary Artery and Saphenous Vein Graft Lesions. TCT,

San Francisco, California, November 2011 24. NIR image interpretation. TCT, San Francisco, California, November 2011 25. Role of thrombectomy in acute MI: evidence and current practice. STEMI Texas meeting held in Dallas, TX

in August 2011. 26. DES vs. BMS in AMI: evidence and current practice. STEMI Texas meeting held in Dallas, TX in August

2011. 27. The antegrade approach to chronic total occlusion angioplasty: SCAI 2011 meeting, Baltimore, Maryland,

May 7, 2011 28. Keeping abreast with the literature: SCAI 2011 meeting, Baltimore, Maryland, May 7, 2011 29. Cath Lab of the future: SCAI 2011 meeting, Baltimore, Maryland, May 7, 2011 30. Acute stent thrombosis: evaluation and management. American College of Cardiology Annual Scientific

Sessions, New Orleans, Louisiana, April 4, 2011 31. Advanced intracoronary imaging. Fourth Russian Congress of Interventional Cardioangiology, April 2011 32. “Bare metal or drug-eluting stents for saphenous vein grafts?” American Heart Association Scientific

Sessions, Chicago Illinois, November 17, 2010 33. 31st Panhellenic Cardiological Society Meeting, Athens Greece (Antiplatelet therapy in PCI today), October

22, 2010 34. Visiting Professor, Hôpital Laval, Quebec City, Canada (Improving SVG patency), September 30, 2010 35. Visiting Professor, University of Arizona and Southern Arizona VAMC (Revascularization in the patient

after coronary artery bypass graft surgery and state of the art management of complications in the cath lab), April 14 and 15, 2010

36. Revascularization in patients with prior CABG, American College of Cardiology meeting, Atlanta, March 15 2010

37. Visiting Professor, University of Kentucky (State of art management of the post-CABG patient and fellows conference on cardiac catheterization complications), November 11 and 12, 2009

38. Risk Stratification, and the Invasive vs. Conservative (non) Controversy, TCT, San Francisco, California, September 2009

39. AMI – Thrombus Containing Lesions. American College of Cardiology i2 meeting, Orlando Florida. March 30, 2009

40. Life after CABG: challenges and opportunities. Cardiology Grand Rounds, Tulane University, New Orleans, Louisiana. October 1, 2008

41. Perioperative Management of Coronary Stents. Cardiology Grand Rounds, Sentara Heart Hospital, Norfolk, Virginia, February 20, 2007

42. Perioperative Management of Coronary Stents. Cardiology Grand Rounds, Onassis Cardiac Surgery Center, Athens, Greece. September 26, 2006

PRESENTATIONS 1. Shorrock D, Michael TT, Patel V, Rangan BV, Abdullah S, Grodin JM, Banerjee S, Brilakis ES. Frequency and

Outcomes of Aortocoronary Dissection During Percutaneous Coronary Intervention of Chronic Total

http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=2840&sKey=5afcc254-dd7e-4d41-b67f-2b44f1a7c6a2&cKey=911f3db0-8de0-4cb6-8c77-ddcf4ad56d7a&mKey=%7b86D3D797-1DEA-4B4D-A5C5-A402B3E95F8C%7d

http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=2840&sKey=5afcc254-dd7e-4d41-b67f-2b44f1a7c6a2&cKey=911f3db0-8de0-4cb6-8c77-ddcf4ad56d7a&mKey=%7b86D3D797-1DEA-4B4D-A5C5-A402B3E95F8C%7d

http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=2840&sKey=45e48dc4-0d4e-4ce2-a436-cc20820c3ca8&cKey=ad5eb394-a74f-4477-960d-dd77667b739d&mKey=%7b86D3D797-1DEA-4B4D-A5C5-A402B3E95F8C%7d

http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=2840&sKey=45e48dc4-0d4e-4ce2-a436-cc20820c3ca8&cKey=ad5eb394-a74f-4477-960d-dd77667b739d&mKey=%7b86D3D797-1DEA-4B4D-A5C5-A402B3E95F8C%7d

25

Occlusions: a Case Series and Systematic Review of the Literature. SCAI Annual Scientific Meeting. Orlando, May 2013

2. Mogabgab O, Patel VG, Michael TT, Fuh, E, Alomar M, Rangan BV, Abdullah S, Banerjee S, Brilakis ES. Mid-Term Outcomes with use of the BridgePoint Medical System for the Recanalization of Coronary Chronic Total Occlusions. SCAI Annual Scientific Meeting. Orlando, May 2013

3. Michael TT, Karmpaliotis D, Brilakis ES, Fuh, E, Patel V, Mogabgab O, Alomar M, Abdullah S, Kirkland B, Lembo N, Anna K, Carlson H, Banerjee S, Lombardi W, Kandzari D. Chronic Total Occlusion Revascularization is Less Successful in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights from a Multicenter US Registry. SCAI Annual Scientific Meeting. Orlando, May 2013

4. Michael TT, Karmpaliotis D, Brilakis ES, Abdullah S, Kirkland B, Lembo N, Anna K, Carlson H, Banerjee S,

Lombardi W, Kandzari D. Temporal Trends of Fluoroscopy time and Contrast Volume in Coronary Chronic Total Occlusion Revascularization: Insight a Multicenter United States Registry. SCAI Annual Scientific Meeting. Orlando, May 2013

5. Michael TT, Mogabgab O, Fuh E, Patel V, Moin D, Alomar M, Papayannis A, Rangan BV, Abdullah S, Banerjee S. Brilakis ES. Application of the “Hybrid Approach” To Chronic Total Occlusion Interventions Is Associated With High Success and Low Complication Rates: a Detailed Procedural Analysis. SCAI Annual Scientific Meeting. Orlando, May 2013

6. Frick K, Michael TT, Abdullah S, Banerjee S, Brilakis ES. Use of low molecular weight dextran provides similar

optical coherence tomography imaging results compared to radiographic contrast media. J Am Coll Cardiol. 2013;61(10_S)

7. Xu H, Brilakis ES, Nguyen KT, Banerjee S. Platelet-mimicking multi-ligand nanoparticles inhibit endothelial cell inflammation and neointimal restenosis. J Am Coll Cardiol. 2013;61(10_S)

8. Alomar ME, Michael TT. Rangan BV, Banerjee S. Brilakis ES. Stent loss and retrieval during coronary

intervention: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;61(10_S)

9. Patel V, Michael TT, Mogabgab O, Fuh E, Lo N, Abdullah S, Banerjee S, Brilakis ES. Clinical, angiographic and procedural predictors of periprocedural complications in coronary chronic total occlusion PCI. J Am Coll Cardiol. 2013;61(10_S)

10. Fuh E, Hester A, Patel V, Mogabgab O, Abdullah S, Banerjee S, Brilakis ES. Saphenous vein graft body lesions

have higher lipid content compared to anastomotic lesions: a near-infrared spectroscopy in vivo study. J Am Coll Cardiol. 2013;61(10_S)

11. Brilakis ES, Held C, Meier B, Cools F, Claeys M, Cornel J, Aylward P, Lewis B, Weaver D, Wognsen GB,

Stevens S, Wallentin L, James S. Extent of Coronary Artery Disease and Outcomes After Ticagrelor Administration: Insights From The PLATelet inhibition and patient Outcomes (PLATO) trial. American Heart Association Scientific Sessions, Los Angeles, California, November 2012

12. Berger PB, Brilakis ES, Best PJ, Orford JL, Sayed II, Forster KB, Henry Y. Frequency of Allergic or

Hematologic Adverse Reactions to Prasugrel in Patients with a Previous Allergic or Hematologic Adverse Reaction to Clopidogrel. American Heart Association Scientific Sessions, Los Angeles, California, November 2012

26

13. Brilakis ES, Michael TT, Papayannis A, Patel V, Fuh E, Alomar M, Moin A, Brayton K, Mogabgab O, Shorrock D, Navara R, Tran D, Roesle M, Rangan BV, Haagen D, Makke L, Abdullah S, Luna M, Addo T, Banerjee S. The “AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusions” (ACE-CTO) Study. Transcatheter Cardiovascular Therapeutics, Miami, Florida, September 2012.

14. Patel V, Brayton K, Mogabgab O, Michael T, Lo N, Alomar M, Shorrock D, Abdullah S, Banerjee S, Brilakis E. Tct-439 incidence of procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: A systematic review and meta-analysis. J. Am. Coll. Cardiol. 2012;60

15. Madder R, Madden S, Puri R, Hendricks M, Vanoosterhout S, Sum S, Kini A, Sharma S, Rizik D, Brilakis E,

Shunk K, Goldstein J, Weisz G, Virmani R, Nicholls S, Maehara A, Mintz G, Stone G, Muller J. Tct-23 detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute st-segment elevation myocardial infarction JACC Cardiovasc Interv. 2012;60

16. Mohammad A, Banerjee A, Baig M, Pershwitz G, Hadidi O, Brilakis E. Tct-352 angiographic features of

atherosclerotic superficial femoral artery disease in diabetics and non-diabetics presenting with claudication. J. Am. Coll. Cardiol. 2012;60

17. Karmpaliotis D, Michael T, Brilakis E, Papayannis A, Tran D, Kirkland B, Lembo N, Anna K, Carlson H,

Banerjee S, Lombardi W, Kandzari D. Tct-455 coronary chronic total occlusion revascularization: Immediate procedural outcomes from a multicenter us registry. J. Am. Coll. Cardiol. 2012;60

18. Michael T, Moin D, Papayannis A, Alomar M, Banerjee S, Brilakis E. Tct-451 application of the “hybrid

approach” to chronic total occlusion interventions. J. Am. Coll. Cardiol. 2012;60

19. Lo N, Michael T, Moin D, Patel V, Alomar M, Papayannis A, Banerjee S, Brilakis E. Tct-454 peri-procedural myocardial infarction in chronic total occlusion percutaneous coronary interventions: A systematic cardiac biomarker evaluation study. J. Am. Coll. Cardiol. 2012;60

20. Banerjee S, Weideman R, Little B, Weideman M, Gunter J, Kelly K, Brilakis E. Tct-717 impact of anti-anginal therapy and rate pressure product control on the need for repeat revascularization post-pci. J. Am. Coll. Cardiol. 2012;60

21. Brilakis E, Held C, Meier B, Cools F, Claeys M, Cornel J, Aylward P, Lewis B, Weaver D, Wognsen GB, Stevens S, Wallentin L, James S. Tct-739 effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: Insights from the platelet inhibition and patient outcomes (plato) trial. J. Am. Coll. Cardiol. . 2012;60

22. Abdel-karim AR, Papayannis AC, Mahmood A, Michael TT, Rangan BV, Makke L, Banerjee S, Brilakis ES.

Role of Embolic Protection Devices in Ostial Saphenous Vein Graft Lesions. Catheter Cardiovasc. Interv. 2012; 79(S1): p. S20. SCAI 2012 Scientific Sessions, Las Vegas, NV, May 2012

23. Rangan BV, Michael TT, Papayannis AC, Banerjee S, Brilakis ES. Acute and Mid-Term Outcomes After Retrograde Recanalization of Coronary Chronic Total Occlusions in a Veteran Population. Catheter Cardiovasc. Interv. 2012; 79(S1): p. S24. SCAI 2012 Scientific Sessions, Las Vegas, NV, May 2012

24. Karmpaliotis D, Michael T, Brilakis ES, Lembo N, Kalynych A, Carlson H, Banerjee S, Kandzari D, Lombardi

W. Retrograde Coronary Chronic Total Occlusion Revascularization: Procedural Outcomes from a Multicenter US Registry. Catheter Cardiovasc. Interv. 2012; 79(S1): p. S17. SCAI 2012 Scientific Sessions, Las Vegas, NV, May 2012

27

25. Papayannis AC, Michael TT, Yangirova D, Abdel-karim AR, Kohlhaas J, Mahmood A, Addo T, Haagen D, Makke L, Roesle M, Rangan BV, Banerjee S, Brilakis ES. Optical Coherence Tomography Analysis of the SOS V Xience Study: The Use of the Everolimus-Eluting Stent in Saphenous Vein Graft Lesions. Catheter Cardiovasc. Interv. 2012; 79(S1): p. S90. SCAI 2012 Scientific Sessions, Las Vegas, NV, May 2012

26. Papayannis AC, Michael TT, Rangan BV, Banerjee S, Brilakis ES. Use of the CrossBoss Catheter in Coronary

Chronic Total Occlusion Due to In-Stent Restenosis. Catheter Cardiovasc. Interv. 2012; 79(S1): p. S17. SCAI 2012 Scientific Sessions, Las Vegas, NV, May 2012

27. Alshawabkeh L, Prasad A, Lenkovsky F, Kandil E, Weideman R, Kelly K, Rangan BV, Banerjee S, Brilakis ES.

Outcomes of a preoperative “bridging” strategy with glycoprotein IIb/IIIa inhibitors for preventing perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration. J. Am. Coll. Cardiol. 2012; 59(13_Suppl_S): p. E502

28. Papayannis AC, Michael TT, Yangirova D, Abdel-karim A-rR, Kohlhaas J, Mahmood A, Addo T, Haagen D, Makke L, Roesle M, Rangan BV, Banerjee S, Brilakis ES. Optical coherence tomography analysis of the SOS Xience V study: the use of the everolimus-eluting stent in saphenous vein graft lesions. J. Am. Coll. Cardiol. 2012; 59(13_Suppl_S): p. E119

29. Michael TT, Banerjee S, Brilakis ES. Distal “Open Sesame” and “Hairpin Wire” Techniques to Facilitate a

Chronic Total Occlusion Intervention. American College of Cardiology Annual Scientific Sessions, Chicago, Illinois, March 24, 2012

30. Michael TT, Banerjee S, Brilakis ES. Retrograde Percutaneous Coronary Intervention Of A Right Coronary Artery Chronic Total Occlusion Using Triple Arterial Access: Separating Visualization From Equipment Delivery. American College of Cardiology Annual Scientific Sessions, Chicago, Illinois, March 24, 2012

31. Abdel-karim A-rR, da Silva M, Lichtenwalter C, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan

BV, Makke L, Jeroudi OM, Raghunathan D, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger PB, Banerjee S, Brilakis ES. Abstract 8423: Prevalence and Outcomes of Intermediate Saphenous Vein Graft Lesions: Findings from the Stenting of Saphenous Vein Grafts Randomized-Controlled Trial. Circulation;124:A8423.

32. Tsai TT, Dattilo PB, Warner J, Donaldson D, Virchow A, Stanislawski MA, O'Donnell CI, Rogers RK, Shunk KA, Jones WS,Kinlay S, Brilakis ES, Klein AP, Casserly IP, Rumsfeld JS. Abstract 16711: Contemporary Treatment and Outcomes of Peripheral Vascular Interventions for Symptomatic Lower Extremity Peripheral Arterial Disease: Insights From the National VA Clinical Assessment, Reporting and Tracking (VA-CART) Program Peripheral Registry. Circulation;124:A16711.

33. Tsai TT, Maddox TM, Nallamothu BK, Stanislawski MA, Adams JC, Box TL, Ho PM, Rao SV, Casserly IP,

Rumsfeld JS, Brilakis ES. Abstract 17341: Use and Effectiveness of Drug-Eluting versus Bare Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions: Insights from the National VA Clinical Assessment, Reporting and Tracking (CART) Program. Circulation;124:A17341.

34. Banerjee S, Das TS, Dippel EJ, Shammas NW, Tran D, Zankar A, Weideman RA, Little BB, Lichtenwalter CS, Dinakaran SK, Mehta PS, Addo TA, Abu-Fadel M, Brilakis ES. Cryoplasty Or Conventional Balloon Post-dilation of Nitinol Stents For Revascularization of Peripheral Arterial Segments (COBRA Trial). J. Am. Coll. Cardiol. 2011;58:XV-XV.

http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=2840&sKey=54e53776-18de-47e9-9294-e1a994c65d0d&cKey=4611c8e1-aa70-47d8-80c6-7b9f61705ccd&mKey=%7b86D3D797-1DEA-4B4D-A5C5-A402B3E95F8C%7d



28

35. Brilakis ES, Papayannis AC, Abdel-Karim ARR, Michael TT, Mahmood A, Makke LB, Roesle M, Haagen D, Rangan BV, Banerjee S. Prospective Evaluation Of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: the Xience V-SVG Angiographic Study. J. Am. Coll. Cardiol. 2011;58:B59-B59.

36. Hakim DA, Maehara A, Banerjee S, Abdel-Karim ARR, Yakushili T, Sum ST, Madden SP, Stone GW, Muller

JE, Brilakis ES. Near infrared spectroscopic assessment of lipid core plaque changes after coronary artery stenting. J. Am. Coll. Cardiol. 2011;58:B179-B179.

37. Xu H, Nguyen KT, Terada LS, Fuh E, Garcia JA, Brilakis ES, Bhatt DL, Banerjee S. Response of Endothelial Progenitor Cells To Antiproliferative Drugs Currently Used in Drug Eluting Stents. J. Am. Coll. Cardiol. 2011;58:B70-B71.

38. Iturbe JM, Abdel-karim AR, Papayannis AC, Mahmood A, Rangan BV, Banerjee S, Brilakis ES. Frequency, Treatment, and Consequences of Device Loss vs.Entrapment in Contemporary Percutaneous Coronary Interventions. Catheter Cardiovasc Interv. 2011; 76: S39

39. Abdel-karim AR, Papayannis AC, Rangan BV, Banerjee S, Brilakis ES. Stenting of Native Coronary Artery Lesions with Large Lipid Core Plaques As Detected By Near-Infrared Spectroscopy Is Associated With High Frequency of Debris Retrieval Using Embolic Protection Devices. Catheter Cardiovasc Interv. 2011; 76: S16

40. Mahmood A, Khair T, Abdel-karim AR, Papayannis AC, Xu H, Banerjee S, Brilakis ES. Embolic Protection Device Utilization in Saphenous Vein Graft Interventions: A Survey of 275 Interventional Cardiologists. Catheter Cardiovasc Interv. 2011; 76: S5

41. Chung P, Abdel-Karim AR, Papayannis AC, Xu H, Banerjee S, Brilakis ES. Effect of a Multifaceted Approach on Shortening Door-to-Balloon Time in Patients with ST-Segment Elevation Acute Myocardial Infarction in a Tertiary Care VA Medical Center. Catheter Cardiovasc Interv. 2011; 76: S4

42. Papayannis AC, Abdel-karim AR, Mahmood A, Michael T, Banerjee S, Brilakis ES. Comparison of Optical Coherence Tomography Findings of Various Drug Eluting Stents. Catheter Cardiovasc Interv. 2011; 77:S25

43. Papayannis AC, Abdel-karim AR, Mahmood A, Michael T, Banerjee S, Brilakis ES. Association of Coronary Lipid Core Plaque with Intra-stent Thrombus Formation: A Near-Infrared Spectroscopy and Optical Coherence Tomography Study. Catheter Cardiovasc Interv. 2011; 77: S133

44. Michael TT, Abdel-karim AR, Papayannis AC, Lichtenwalter, C, de Lemos JA, Obel OO, Addo TA, Roesle M,

Haagen D, Rangan BV, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger, PB, Banerjee S, Brilakis ES. Recurrent Cardiovascular Events with Paclitaxel-Eluting vs. with Bare-Metal Stents in Saphenous Vein Graft Lesions: Insights from the SOS (Stenting Of Saphenous vein grafts) Trial. Catheter Cardiovasc Interv. 2011; 76: S125

45. Raghunathan D, Abdel-karim AR, Papayannis AC, daSilva M, Jeroudi O, Rangan BV, Banerjee S, Brilakis ES. Association between the Presence and Extent of Coronary Lipid Core Plaques Detected by Near-Infrared Spectroscopy With Post Percutaneous Coronary Intervention Myocardial Infarction. J. Am. Coll. Cardiol. 2011; 57(14_Suppl_S): p. E1652

46. Michael TT, Badhey N, Banerjee S, Brilakis ES. Comparison of Characteristics and Outcomes of Saphenous Vein Graft Patients Who Were vs. Those Who Were Not Enrolled in the Stenting Of Saphenous Vein Grafts Randomized Controlled Trial. J. Am. Coll. Cardiol. 2011; 57(14_Suppl_S): p. E1691

29

47. Brilakis ES, Berger PB, Lasala JM, Cox DA, Starzyk RM, Dawkins KD. Two-Year Outcomes after Utilization of the TAXUS Paclitaxel-Eluting Stent in Bifurcations and Multivessel Stenting in the ARRIVE Registries. J. Am. Coll. Cardiol. 2011; 57(14_Suppl_S): p. E1717

48. Abdel-karim AR, Rangan BV, Banerjee S, Brilakis ES. Inter-Catheter Reproducibility of Near-Infrared Spectroscopy for the In-Vivo Detection of Coronary Lipid Core Coronary Plaques. J. Am. Coll. Cardiol. 2011; 57(14_Suppl_S): p. E1871

49. Luna M, Holper E, Banerjee S, Brilakis ES. Inter-Use of the Guideliner Catheter to Facilitated Complex Coronary and Bypass Graft Interventions. J. Am. Coll. Cardiol. 2011; 57(14_Suppl_S): p. E1884

50. Brilakis ES, Rao SV, Banerjee S, Goldman S, Shunk K, Holmes DR, Honeycutt E, Roe MT. Percutaneous Coronary Intervention in Native Arteries vs. Bypass Grafts in Prior Coronary Bypass Grafting Patients: A Report from NCDR. J. Am. Coll. Cardiol. 2011; 57(14_Suppl_S): p. E1960

51. Banerjee S, Ahmad I, Master R, Weideman R, Little B, Rao SV, Brilakis ES. Dual antiplatelet therapy following coronary artery bypass surgery: predictors and outcomes. J. Am. Coll. Cardiol. 2011; 57(14_Suppl_S): p. E1921

52. Townsend JC, Steinberg DH, Nielsen CD, Todoran TM, Zwemer PL, McCarty CP, McManus WJ, Sneed JD, Patel CP, Leonardi RA, Brilakis ES, Shunk KA, Goldstein JA, Kern MJ, Maini B, Powers ER. Intracoronary Lipid Burden at Bifurcations: Results from the COLOR Registry. J. Am. Coll. Cardiol. 2011; 57(14_Suppl_S): p. E1472

53. Tolerico PH, Cohen DJ, Kleiman NS, Berger PB, Brilakis ES, Piana RN, Shammo S, Keyes MJ, Kennedy KF,

Massaro JM, Saucedo JF. Improved Outcomes with Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Interventions: A Report From the Evaluation of Drug-Eluting Stents and Ischemic Events Registry. J. Am. Coll. Cardiol. 2011; 57(14_Suppl_S): p. E1761

54. Steinberg DH, Townsend JC, Bonnema DD, Hilty KC, McCarty CP, Nielsen CD, Zwerner PL, Brilakis ES, Prasad A, Maini BS, Shunk KA, Patel P, Kern MJ, Powers ER. Abstract 18425: Intracoronary Lipid Burden in Diabetic Patients Undergoing Cardiac Catheterization: Results from the COLOR Registry. Circulation 2010;122:A18425

55. Brilakis ES. “Ping-pong guide catheter technique for ipsilateral retrograde chronic total occlusion intervention. TCT 2010 meeting, Washington DC, September 2010

56. Brilakis ES. Carotid artery disease and approach to non-ST segment elevation acute myocardial infarction. Board review course. TCT 2010 meeting, Washington DC, September 2010

57. Wood FO, Garcia B, Badhey N, Garcia B, Abdel-karim AR, Maini B, Banerjee S, Brilakis ES. Analysis of Saphenous Vein Graft Lesion Composition Using Near-infrared spectroscopy and Intravascular Ultrasonography with Virtual Histology. SCAI 2010 Scientific Sessions, San Diego, California, May 2010

58. Iturbe JM, Abdel-karim AR, Raja VN, Rangan BV, Banerjee S, Brilakis ES. Use of the Venture Wire Control Catheter for the Treatment of Coronary Artery Chronic Total Occlusions. SCAI 2010 Scientific Sessions, San Diego, California, May 2010

59. Saeed B, Kandzari DE, Agostoni P, Lombardi WL, Rangan BV, Banerjee S, Brilakis ES. Use of Drug-Eluting Stents for Chronic Total Occlusions: a Systematic Review and Meta-analysis. SCAI 2010 Scientific Sessions, San Diego, California, May 2010

30

60. Brilakis ES, Wang TY, Rao SV, Banerjee S, Dai D, Chin CT, Harding TM, Roe MT. Frequency and Predictors

of Drug-Eluting Stent Use in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions: A Report from the American College of Cardiology - National Cardiovascular Data Registry. American College of Cardiology meeting, Atlanta, March 2010 J. Am. Coll. Cardiol. 2010; 55(10_MeetingAbstracts): p. A200.E1878

61. Lichtenwalter C, de Lemos JA, Obel O, Abdel-karim AR, Roesle M, Haagen D, Saeed B, Bissett JK, Sachdeva

R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger PB, Banerjee S, Brilakis ES. Persistent Benefit From Paclitaxel-Eluting Stent Implantation in Saphenous Vein Grafts: Long-Term Results of the Stenting Of Saphenous Vein Grafts (SOS) Trial. American College of Cardiology meeting, Atlanta, March 2010 J. Am. Coll.

Cardiol. 2010; 55(10_MeetingAbstracts): p. A193.E1808

62. Garcia B, Wood F, Cipher D, Banerjee S, Brilakis ES. Reproducibility of Near-Infrared Spectroscopy for the

Detection of Lipid Core Coronary Plaques and Observed Changes After Coronary Stent Implantation. American College of Cardiology meeting, Atlanta, March 2010 J. Am. Coll. Cardiol. 2010; 55(10_MeetingAbstracts): p. A94.E888

63. Abdel-karim AR, Banerjee S, Brilakis ES. Percutaneous Intervention of Acutely Occluded Saphenous Vein

Grafts: Contemporary Techniques and Outcomes. American College of Cardiology meeting, Atlanta, March 2010 J.

Am. Coll. Cardiol. 2010; 55(10_MeetingAbstracts): p. A189.E1764

64. Maini B, Brilakis ES, Kim M, Hendricks MJ, Madden SP, Sum ST, Muller JE, Rizik D, Dixon SR. Infrared Detection of Large Lipid Core Plaque as a Potential Predictor for Peri-Procedural MI. American College of Cardiology meeting, Atlanta, March 2010 J. Am. Coll. Cardiol. 2010; 55(10_MeetingAbstracts): p. A179.E1672

65. Brilakis ES, Banerjee S. Hairpin-Trap: a novel stent retrieval technique. American College of Cardiology meeting,

Atlanta, March 2010

66. Brilakis ES, Banerjee S. Use of a Septal Dilator During a Retrograde CTO Intervention. American College of Cardiology meeting, Atlanta, March 2010

67. Brilakis ES, Berger PB, Lasala JM, Cox DA, Starzyk RM, Dawkins KD, Baim DS. Clinical Outcomes Post

Implantation of the Paclitaxel-Eluting Stent in Saphenous Vein Graft Lesions in Routine Clinical Practice: Insights from the ARRIVE 1 and ARRIVE 2 Registries. EuroPCR, Barcelona, Spain, May 2009

68. Lichtenwalter C, Banerjee S, de Lemos JA, Roesle M, Obel O, Holper E, Haagen D, Shunk K, Bissett JK,

Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger PB, Brilakis ES. Comparison of the angiographic patterns and clinical presentation of in-stent restenosis between a paclitaxel-eluting and a bare metal stent in saphenous vein graft lesions: insights from the SOS (Stenting Of Saphenous vein grafts) trial. SCAI meeting, Las Vegas, May 2009

69. Parikh SV, de Lemos JA, Jessen M, Brilakis E, Chen AY, Wang T, Roe M, Holper E. Timing of In-Hospital

Coronary Artery Bypass Graft in Relationship to Mortality for Acute Coronary Syndrome Patients: Results From the NCDR ACTION Registry. American College of Cardiology meeting, Orlando, March 2009

70. Gandhi NK, Banerjee S, Brilakis ES. Frequency and Risk of Noncardiac Surgery After Drug-Eluting Stent Implantation. American College of Cardiology meeting, Orlando, March 2009

71. Dimitrov I, Haider A, Douglas D, Brilakis ES, Banerjee S, Malloy C. Extended RF Heating Study of Cardiac

and Peripheral Stents at 7 T. International Society for Magnetic Resonance in Medicine Annual Meeting. Honolulu, Hawai April 2009

http://apps.isiknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=1&SID=2CLJ4GPaNBjbd482g9P&page=1&doc=4&colname=WOS



31

72. Brilakis ES, Hernandez AF, Dai D, Fonarow GC, Cannon CP, Bhatt DL. Secondary Prevention Performance Measures in Acute Coronary Syndrome Patients With Prior Monovascular or Polyvascular Atherosclerosis in the Get With the Guidelines Database. Circulation. 2008; 118(18_MeetingAbstracts):S_970-b

73. Philip E Greilich PE, Satyanarayana N, Brilakis ES, May T, Leonard D, Banerjee S, Jessen ME. Epsilon-

aminocaproid acid but not aprotinin increases myocardial injury following isolated coronary artery bypass grafting. American Society of Anesthesiologist Annual Meeting 2008.

74. Brilakis ES. The SOS (Stenting Of Saphenous vein grafts) randomized controlled trial of a paclitaxel-eluting vs.

a similar bare metal stent in saphenous vein graft lesions. Late breaking trial presentation at Transcatheter Cardiovascular Therapeutics meeting, October 14, 2008.

75. Brilakis ES, de Lemos JA, Cannon CP, Wiviott SD, Murphy SA, Morrow DA, Sabatine MS, Banerjee S, Blazing

MA, Califf RM, Braunwald E. Outcomes of Patients With Acute Coronary Syndromes and Prior Coronary Artery Bypass Grafting. Results From the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE-IT-TIMI 22) and the Aggrastat to Zocor (A to Z) trials. Circulation. 2007; 116: II_314

76. Brilakis ES, Khera A, McGuire DK, Murphy SA, de Lemos JA. Race and Gender Differences in Lipoprotein-

Associated Phospholipase A2 Levels: Results From the Dallas Heart Study. American Heart Association Meeting, Chicago, Illinois, November 2006

77. Compton PA, Zankar AA, Adesanya AO, Banerjee S, Brilakis ES. Risk of Non-Cardiac Surgery After Coronary

Drug-Eluting Stent Implantation. ESC Congress Barcelona, Spain, September 2006 78. Brilakis ES. Association between Lp-PLA2 and Cardiovascular Events in a Secondary Prevention Population.

Satellite Symposium“The Emerging Role of Lp-PLA2 in plaque vulnerability“. Satellite Symposium of ESC Congress 2005. Stockholm Sweden, September 2005

79. Tsimikas S, Brilakis ES, Miller ER, McConnell, JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB.

Circulating OxLDL-E06 Levels Reflect the Presence and Extent of Angiographic Coronary Artery Disease: Strong Association Between Circulating Oxidized Phospholipids and Lp(a) May Potentially Mediate Atherogenicity. AHA meeting, New Orleans, November 2004

80. Brilakis ES, Best PJ, Barsness GW, Holmes DR, Rihal CS, Garratt KN. Incidence, Retrieval Methods, and

Outcomes of Stent Loss During Percutaneous Coronary Intervention: A Large Single Center Experience. Am J Cardiol 2004; 94 (supplement):45E

81. Brilakis ES, McConnell JP, Lennon RJ, Elesber AA, Meyer JG, Berger PB. The value of novel coronary artery

disease risk factors in the prediction of cardiovascular events. 5th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington DC May 2004

82. Brilakis ES, McConnell JP, Lennon RJ, Elesber AA, Meyer JG, Berger PB. Prevalence of traditional coronary

artery disease risk factors among patients with angiographic coronary artery disease. Arterioscl Thromb Vas Biol 2004; 24: P412

83. Brilakis ES, Orford JL, Fasseas P, Wilson SH, Melby S, Lennon RJ, Berger PB. Clinical Outcome of Patients

Undergoing Balloon Angioplasty vs. Stent Placement in the Two Months Prior to Non-Cardiac Surgery. Society for Cardiovascular Angiography and Interventions (SCAI) 27th Annual Scientific Sessions, San Diego, California, April 2004

32

84. Brilakis ES, McConnell JP, Lennon RJ, Elesber AA, Meyer JG, Berger PB. Association of Common Interleukin 1 Gene Variations With Cardiovascular Events at Follow-Up. J Invest Med 2004;52:S377

85. Brilakis ES, McConnell JP, Lennon RJ, Elesber AA, Meyer JG, Berger PB. Higher Levels of Lipoprotein-

Associated Phospholipase A2 Are Associated With Higher Incidence of Cardiovascular Events at Follow-Up Independent of C-reactive Protein. JACC 2004;43 Suppl A:454A

86. Wolk R, Berger P, Lennon RJ, Brilakis ES, Johnson BD, Somers VK. Plasma leptin level is an important and

independent predictor of prognosis in patients with established coronary atherosclerosis. JACC 2004;43 Suppl A:535A

87. Brilakis ES, McConnell JP, Lennon RJ, Meyer JG, Berger PB. Lipoprotein-Associated Phospholipase A2 levels

are lower in women compared to men because of a significant negative correlation with HDL cholesterol. Circulation 2003;107:P45

88. Brilakis ES, McConnell JP, Lennon RJ, Meyer JG, Berger PB. Lipoprotein-Associated Phospholipase A2 is

associated with angiographic coronary artery disease on univariate analysis but loses independent predictive value in a multivariate model. JACC 2003;41 Suppl A:283A

89. Brilakis ES, Friedman PA, Maounis TN, Rokas SG, Shen WK, Stamatelopoulos SF, Cokkinos DV. Dilated

cardiomyopathy and syncope: role of programmed ventricular stimulation. XIIth World Congress on Cardiac Pacing and Electrophysiology. Hong Kong, February 2003.

90. Brilakis ES, Wright RS, Kopecky SL, Reeder, GS, Rihal CS, Gersh BJ, Williams BA, Clements IP. The

PURSUIT risk score correlates with ejection fraction and angiographic findings in non-ST elevation acute myocardial infarction. Eur Heart J 2002;23:719

91. Williams BA, Wright RS, Clements IP, Brilakis ES, Smars PA, Murphy JG, Reeder GS, Jaffe AS. A prognostic

risk score for 30-day mortality after acute myocardial infarction in a community-based population. Eur Heart J 2002;23:103

92. Hassan I, Brilakis ES, Thompson RL, Que FG. Surgical management of abdominal tuberculosis. Digestive

Diseases Week, San Francisco, May 2002. 93. Brilakis ES, Mavrogiorgos NC, Kopecky SL, Wright RS, Reeder, GS, Gersh BJ, Williams BA, Clements IP. Use

of the PURSUIT risk score for predicting late mortality in a non-selected, community-based population with both ST-elevation and non-ST elevation acute myocardial infarction. Circulation 2001;104: 3286 Suppl. S

94. Brilakis ES, Mavrogiorgos NC, Kopecky SL, Wright RS, Reeder, GS, Gersh BJ, Williams BA, Clements IP.

Validation of the TIMI risk score for ST-elevation acute myocardial infarction in a community-based coronary care unit registry. Circulation 2001;104:1811 Suppl. S

95. Brilakis ES, Wright RS, Kopecky SL, Reeder GS, Mavrogiorgos NC, Williams BA, Miller WA. Bundle-branch

block as a predictor of long-term survival after acute myocardial infarction: results from a community-based population. Eur Heart J 2001;22: 71 Suppl. S

96. Brilakis ES, Mavrogiorgos NC, Kopecky SL, Gersh BJ, Williams BA, Clements IP. Mild QRS Prolongation Is

Associated With Increased Mortality in Non-ST Elevation Acute Myocardial Infarction. J Invasive Cardiol 2001;13:475

33

97. Cha YM, Brilakis ES, Rea RF, Shen WK, Munger TM, Luria D, Hammill SC, Redfield, MM, Friedman PA. Impact of left ventricular dysfunction on survival in implantable cardiovert-defibrillators recipients. J Card Fail 2001 Sep;7(3 Suppl 2):3

98. Brilakis ES, Rasmussen MJ, Lexvold N, Shen WK, Rea RF, Hayes DL, Hammill SC, Friedman PA. Indications

and frequency of dual chamber ICD use. J Am Coll Cardiol 2001;37:136A Suppl. A 99. Brilakis ES, Valverde A, Luria D, Cha YM, Scott C, Rea RF, Friedman PA, Shen WK. Survival after

implantation of an implantabe cardioverter-defibrillator in elderly patients. J Am Coll Cardiol 2001;37:108A Suppl. A

100. Brilakis ES, Kopecky SL, Williams BA, Vinar JT, Clements IP. Use of the PURSUIT risk score can provide

accurate early risk stratification in a non-selected, community-based population with non-ST elevation acute myocardial infarction. J Am Coll Cardiol 2001;37:344A Suppl. A

101. Slobodova A, Brilakis ES, Garratt KN, Tilbury TR. Contrast-induced transient cortical blindness after

coronary angiography. American College of Physicians Scientific Meeting, Minnesota Chapter, November 2000 102. Slobodova A, Brilakis ES, Nyman MA. Thirty-three-year-old man with vitiligo and syncope. American College

of Physicians Scientific Meeting, Minnesota Chapter, November 2000

103. Brilakis ES, Kopecky SL, Gersh BJ, Clements IP. QRS Duration 100 ms in the Absence of Left or Right Bundle Branch Block is an Early Predictor of Survival in Non-ST Elevation Acute Myocardial Infarction. Eur Heart J 2000;21:2761 Suppl. S

104. Brilakis ES, Luria D, Shen WK, Rea RF, Rasmussen MJ, Lexvold N, Hammill SC, Friedman PA. Effects of

defibrillation threshold (DFT) testing on the defibrillator implant procedure: Is DFT testing necessary? Pacing Clin Electrophysiol 2000 Apr;23(4 Part II):655

105. Brilakis ES, Olson EJ, McGregor CGA, Olson LJ. Sleep apnea in heart transplant recipients: type,

symptoms, risk factors, and response to nasal continuous positive airway pressure. American Thoracic Society Annual Meeting, Toronto, May 2000

106. Brilakis ES, Chen L, Friedman PA Wide QRS tachycardia refractory to pharmacologic interventions and

cardioversion. J Gen Intern Med 2000; 15: 171 Suppl. 1 107. Brilakis ES, Kamath PS. Cyanosis after pharyngeal spraying with benzocaine. Southern Medical Association 93rd

Annual Meeting,, Dallas, November 1999 108. Brilakis ES, Shen WK, Hammill SC, Friedman PA. Improved survival with device therapy in patients with

idiopathic dilated cardiomyopathy and syncope. Circulation 1999;100:3391 Suppl. S 109. Brilakis ES, Duncan A, Thompson RL. Abdominal tuberculosis in a low incidence area of the world.

American Society of Microbiology 39th ICAAC, San Francisco, September 1999 110. Brilakis ES. Massive pulmonary embolism presenting as recurrent syncope. J Am Geriatr Soc 1999;47:81 111. Brilakis ES, Olson LJ, Daly RC, Cooper LT. Survival outcomes of patients with giant-cell myocarditis

bridged by ventricular assist devices. J Heart Lung Transplant 1999;18:43-4

34

112. Brilakis ES, Munger TM. Reversible catecholamine-induced cardiomyopathy. Fifth World Hellenic Biomedical Conference, New York, December 1998

MODERATOR IN MEETINGS

1. ACC 2011 Chronic Total Occlusion, April 3, 2011 2. AHA 2010 Pathophysiology and risk in acute coronary syndromes, November 16, 2010 3. TCT 2010 interventional board review and complex case auditorium., September 21-25, 2010 4. TCT 2009 interventional board review and complex case auditorium., September 23-25, 2009 5. ACCi2 2009 oral contributions and moderated poster session, Chicago, March 30, 2009 6. SCAI-ACCi2 2008 Moderated poster session, Chicago, March 30 2008 7. ACCi2 2009. Moderator and challenging case presenter, Orlando, March 30 2009

EDUCATIONAL ACTIVITIES

1. Dallas Cardiovascular Innovations meeting: o 12/17/2011, Westin Galleria, Dallas, Texas. o 12/8/2012, UT Southwestern Medical Center, Dallas, Texas

2. Complex Coronary Interventions Webcasts: A webcast with focus on percutaneous interventions in patients

with prior coronary bypass graft surgery and patients with chronic total occlusions: o CCI I: 9/14/2009 o CCI II: 3/12/2010 o CCI III: 5/19/2010 o CCI IV: 11/10/2010 o CCI V: 3/15/2011 o CCI VI: 10/25/2011 o CCI VII: 1/10/2012 o CCI VIII: 7/24/2012 o CCI IX: 2/27/2013

3. VA CTO Club: a VA interventionalists’ forum for exchanging tips and tricks on how to approach chronic total

occlusions. Organized in collaboration with Tom Tsai from Denver VAMC: o Session 1: 3/26/2010 o Session 2: 6/30/2010 o Session 3: 10/13/2010 o Session 4: 12/8/2010 o Session 5: 5/11/2011 o Session 6: 11/3/2011 o Session 7: 1/25/2012 o Session 8: 4/18/2012 o Session 9: 6/14/2012 o Session 10: 11/28/2012 o Session 11: 2/6/2013

4. Editorial consultant for ACP-PIER (American College of Physicians – Physician’s Information and Education Resource chapter: “Perioperative Cardiac Risk Assessment. 2007-2010

35

5. Abelardo A. Martinez-Rumayor AA, Banerjee S, Brilakis ES. “Knuckle Wire and Stingray Balloon for Recrossing a Coronary Dissection After Loss of Guidewire Position.” CardioSource.org. July 31, 2013. Accessed 8/4/2013, from http://www.cardiosource.org/Science-And-Quality/Case-Challenges/2013/07/Knuckle-Wire-and-

Stingray-Balloon.aspx.

MENTORSHIP 1. Anna Kotsia, MD: research fellow, 2013-2015 2. George Christopoulos, MD, PhD: research fellow, 2013-2015 3. Siddharth Patel, BS: medical student, summer 2013 4. Nagendra Pokala, BS: medical student, summer 2013 5. Rohan Menon, BS: medical student, summer 2013 6. Vishal Patel, MD: interventional cardiology fellow, 2012-2014 7. Eric Fuh, MD: interventional cardiology fellow: 2012-2014 8. Owen Mogabgab, MD: interventional cardiology fellow: 2012-2014 9. Daniel Sherbet, MD: interventional cardiology fellow: 2012-2013 10. Mohammad Alomar, MD: research fellow 2012-2013 11. Tesfaldet Michael, MD: NIH fellow 2011-2013 12. Aristotelis Papayannis, MD: research fellow 2010-2012 13. Neeraj Badhey, MD: UTSW interventional cardiology fellow, 2009-2011 14. Arif Mahmood, MD: research fellow 2010-2011 15. Abdul-rahman Riyad Abdel-karim, MD: research fellow 2009-2011 16. Christopher Lichtenwalter: UTSW interventional cardiology fellow, 2008-2010 17. Frances Wood, MD: resident in Internal Medicine, 2009-2010 18. Bobby Garcia: UTSW medical student, summer 2009 19. Julia Kolhaas: UTSW medical student, summer 2009 20. Nainesh Gandhi: UTSW resident in Internal Medicine, 2008-2009 21. Tarif Khair, MD: UTSW resident in Internal Medicine, 2008-2009 22. Vijay Raja, MD: UTSW resident in Internal Medicine, 2008-2009 23. Billy Dimas, MD: UTSW cardiology fellow, 2007-2008 24. Michael Luna, MD: UTSW internal medicine resident, 2007-2008 25. Indu Varghese, MD: research fellow, 2007-2008 26. Amit Prasad, MD: UTSW resident in Internal Medicine, 2007-2008 27. Jad Daye: UTSW medical student, summer 2007 28. Calvin Peters: UTSW medical student, summer 2007 29. Dustin Boatman: UTSW medical student, summer 2007 30. Jose-Miguel Iturbe: UTSW medical student, summer 2006 31. P. Alexander Compton, MD: UTSW resident in Internal Medicine, 2005-2006 32. Anand Prasad, MD: UTSW cardiology fellow, 2005-2006

HONORS AND AWARDS

2012 Researcher of the Year Award. VA North Texas Healthcare System and Dallas VA Research Corporation

2011 Researcher of the Year Award. VA North Texas Healthcare System and Dallas VA Research Corporation

2009 William W. Parmley Young Author Achievement Award. Journal of the

http://www.cardiosource.org/Science-And-Quality/Case-Challenges/2013/07/Knuckle-Wire-and-Stingray-Balloon.aspx

http://www.cardiosource.org/Science-And-Quality/Case-Challenges/2013/07/Knuckle-Wire-and-Stingray-Balloon.aspx

36

American College of Cardiology

2009 CRT 2009 Young Leadership Award for Interventional Cardiology. Cardiovascular Research Technologies, Washington DC,

2007 “Get With The Guidelines” Young Investigator Database Research Award American Heart Association

2006 TCT 2006 Interventional Jeopardy winner. Transcatheter Cardiovascular Therapeutics, Washington DC, 2006

2004 Aventis Travel Award, to attend the First Annual Cardiology Fellowship

Conference and the 2004 American College of Cardiology meeting, Chicago 2004 2004 Clinical Research 2004 Meeting, Trainee Travel Award, to attend the 2004

Clinical Research meeting 2003 ACCF/Bristol Myers Squibb Affiliate Travel Award, to attend the 2003

American College of Cardiology meeting 2002 Mayo Individual Award for Excellence, Mayo Clinic 2002 Netherlands Institute for Health Sciences (NIHES) Fellowship, to attend

the 2002 Erasmus summer program in clinical research 2000 Outstanding Achievement Award, Mayo Clinic Internal Medicine Residency

Program 1997 Clinical Vignette Award, American College of Physicians Scientific Meeting,

Minnesota Chapter 1997-2001 ‘Kontoleontos Foundation’ Scholarship: monthly stipend awarded to the top

medical graduates of Athens University after examination 1991-5 ‘Papadakis Foundation’ Scholarship: monthly stipend awarded to the top

medical students of Athens University after examination 1993 European Community Erasmus Scholar, University Pierre et Marie Curie, Paris

VI, France 1991-4 ‘State Scholarships Foundation’ Awards: awarded to the top medical students

of Athens University every year CLINICAL TRIAL PARTICIPATION (LOCAL PI)

2005-2008 EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (enrolled 20 patients)

2005-2007 Triton-TIMI 38: A Comparison of CS-747 and Clopidogrel in Acute Coronary

Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention (enrolled 1 patient)

37

2007-2009 PLATO: A Comparison of AZD6140 and Clopidogrel in Patients With Acute

Coronary Syndromes (enrolled 12 patients) 2007-2010 VA-CARDS: VA Coronary Artery Revascularization in Diabetes Study (enrolled

39 patients - #1 enrolling center nationwide) 2008-2010 Champion Platform: Cangrelor versus standard therapy to achieve optimal

management of platelet inhibition (enrolled 28 patients) 2008-2012 ROCHE NC20971 (dal outcomes): A study to evaluate effects of RO4607381

on CV risk in stable CHD patients, with documented recent ACS (enrolled 15 patients)

2008- V710: A Study of Staphylococcus aureus Vaccine (V710) in Adult Patients

Scheduled for Open-Heart Surgery (enrolled 10 patients) 2009-2011 TRACER: Trial to Assess the Effects of SCH 530348 in Preventing Heart Attack

and Stroke in Patients With Acute Coronary Syndrome (enrolled 13 patients) 2009-2011 SATURN: Study Of Coronary Atheroma by Intravascular Ultrasound: Effect fo

Rosuvastatin Versus AtorvastatiN (enrolled 14 patients) 2009- COLOR: Chemometric Observations of Lipic Core Containing Plaques of

Interest in Native Coronary Arteries Registry (enrolled 168 patients, #1 enroller nationwide)

2009-2011 APPRAISE-2: Double-blind evaluation of the Safety and Efficacy of Apixaban In

Subjects with a Recent Acute Coronary Syndrome (enrolled 1 patient) 2009- ENGAGE – AF – TIMI 48: A Study to Evaluate Efficacy and Safety of DU-

176b Vs. Warfarin In Subjects with Atrial Fibrillation (enrolled 5 patients) 2010- CYPRESS: A Prospective, Randomized, Multi-Center, Double-Blind Trial to

Assess the Effectiveness and Safety of Different Durations of Dual Anti-Platelet Therapy (DAPT) in Subjects Undergoing Percutaneous Coronary Intervention with the CYPHER® Sirolimus-eluting Coronary Stent (enrolled 10 patients)

2010-2011 FAST CTOs: Facilitated Antegrade Steering Technique in Chronic Total Occlusions Study (enrolled 13 patients)

2010- TAO: Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy (enrolled 12 patients)

2010- dal-plaque II: A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease (enrolled 16 patients)

2010- Champion Phoenix: A Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects who Require PCI (enrolled 33 patients)

38

2011- GE-145 320: Study of GE-145 320 mg-I/mL Injection Versus Iopamidol 370 mg-

I/mL in Elderly Patients Undergoing Coronary Artery Catheterization (enrolled 39 patients, #1 enroller nationwide)

2011- CANARY: Coronary Assessment by Near-Infrared of Atherosclerotic Rupture-prone Yellow (enrolled 2 patients)

2011- PEGASUS-TIMI 54: Prevention of Thrombotic Events with Ticagrelor vs. Placebo on a Background of Aspirin Therapy in Patients With History of Myocardial Infarction (enrolled 5 patients)

2011-2012 VISTA 16: Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndromes: Vascular Inflammation Suppression to Treat Acute coronary syndromes for 16 weeks) (enrolled 1 patient)

2011- CHI-SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression (enrolled 13 patients)

2012- EXCEL: Evaluation of Xience Prime versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (enrolled 3 patients)

2012- EXPERT CTO: Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions (enrolled 5 patients)

2013- GLAGOV: GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound

2013- CAESA: Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina (enrollment not started yet)

2013- PRESERVE - CSP#578: Prevention of Serious Adverse Events Following Angiography (enrollment not started yet)

EDITORIAL BOARD MEMBER 1. Catheterization and Cardiovascular Interventions (appointed 2011) 2. Cardiology Today Interventions (appointed 2011) 3. JACC: Cardiovascular Interventions (appointed 2012)

REVIEWER FOR JOURNALS 1. The Lancet 2. JAMA 3. Journal of the American College of Cardiology 4. JACC: Cardiovascular Interventions 5. Circulation 6. Circulation Cardiovascular Interventions 7. European Heart Journal

39

8. American Heart Journal 9. American Journal of Cardiology 10. Catheterization and Cardiovascular Interventions 11. Journal of Invasive Cardiology 12. Journal of Interventional Cardiology 13. Eurointervention 14. Journal of Clinical Endocrinology and Metabolism 15. Journal of Investigative Medicine 16. Hellenic Journal of Cardiology 17. Acute Cardiac Care 18. Heart and Lung 19. Case Reports in Medicine 20. Pharmaceuticals 21. Interventional Cardiology 22. Clinical Cardiology 23. Hospital Practice 24. Heart International 25. Cardiovascular Revascularization Medicine 26. International Journal of Cardiology

CERTIFICATION

2006- American Board of Vascular Medicine, Board certification in Endovascular Medicine

2006- American Board of Vascular Medicine, Board certification in Vascular Medicine

2004- American Board of Internal Medicine, Board certification in Interventional Cardiology

2003- American Board of Internal Medicine, Board certification in Cardiovascular Diseases

2003- National Board of Echocardiography 2000-2010 American Board of Internal Medicine, Board certification in Internal Medicine

PARTICIPATION IN ORGANIZATIONS

2013-2014 TCT at ACC 2014, Interventional Imaging and Physiology Working Group 2012-2015 Co-chair, Interventional Career Development Committee, Society for Cardiac

Angiography and Interventions (SCAI) 2012- Co-chair, eSCAI Webinar Series 2013-2016 Co-chair, eSCAI Committee 2013-2016 2010-2012

Member, Research and Publications Committee for CART-CL, Veterans Affairs Health Administration national cath lab database

2011- Associate director, Transcatheter Cardiovascular Therapeutics Conference Interventional Cardiology Board Review Course with Self-Assessment and Maintenance of Certification (MOC) Sessions

2009-2015- Member, Annual Scientific Sessions Exhibit Committee, American College of Cardiology

2009- Member, i2 Summit Program Committee, American College of Cardiology 2011-2014 Member, Interventional Scientific Council, American College of Cardiology 2011- Member, Invasive Imaging and Physiology Working Group, American College of

40

Cardiology PROFESSIONAL MEMBERSHIPS AND SOCIETIES

2008- American Federation for Medical Research 2006- Hellenic Cardiological Society 2003- Society for Cardiovascular Angiography and Interventions (FSCAI) 2000- American Heart Association, Council of Clinical Cardiology 2000- American College of Cardiology (FACC) 2008- European Society of Cardiology (FESC)

LANGUAGES

Fluent in French, English, Greek.

Documents

Emmanouil S. Brilakis, MD, PhD - UT Southwestern Medical ...€¦ · office: 214-857-1547 fax: 214-302-1341 [email protected] [email protected] [email protected]